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SUMMARY 
The discovery of giant mimivirus in 2003 challenged the classical dogmas of virology: 
viruses were thought to be small, filterable agents that strongly depend on their host 
and contain a minimal number of genes for replication. Mimivirus with a particle size of 
500 nm, however, is not only bigger in size than many parasitic or free-living microbes, 
mimivirus is also huge in genome size with 1.2 Mbp and 1’262 putative coding genes. 
Many of the mimivirus genes were never described in viruses before and were 
considered hallmark genes of cellular life. These genes feature tRNA synthases, 
enzymes involved in DNA repair, chaperones, and metabolic enzymes. The mimivirus 
genome also features a set of genes composing what appears to be a functional 
glycosylation machinery. Conventional viruses hijack the glycosylation machinery of 
their host and, with few examples, do not encode glycosyltransferases. There is only one 
example of another giant virus with a host independent glycosylation machinery known 
to date. Paramecium bursaria Chlorella virus encodes functional glycosyltransferases 
that are involved in the formation of virus-specific glycans for example on the major 
capsid protein. In mimivirus the host-independent synthesis for three nucleotide-
diphospho sugars, namely UDP-N-acetylgulcosamine, UDP-rhamnose, and UDP-
viosamine has been described. In 2011 a first glycosyltransferase of mimivirus was 
described. Mimivirus L230 encodes a bi-functional collagen-modifying enzyme 
hydroxylating lysine residues and glucosylating the latter. Nothing is known about the 
other eleven putative mimivirus glycosyltransferases. In this thesis, we investigated the 
functionality of six of these glycosyltransferases in vitro. 
The putative glycosyltransferases were cloned and expressed in E. coli as His-fusion 
proteins. Protein expression and purification by affinity chromatography was possible 
for five glycosyltransferases, namely L193, R139, R363, R654, and R707. L373 was cloned 
and expressed in Spodoptera frugiperda Sf9 cells as FLAG-fusion protein. To gain an 
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idea about the possible functionality of our candidate genes, we analyzed the sequences 
using bioinformatics tools. Using the results from the sequence analysis together with 
the known monosaccharide composition of mimivirus and known O-glycan structures 
we tested the glycosyltransferase activity of the candidate proteins in vitro. Mimivirus 
R707 was identified as glycogenin-1 homolog that elongated glucose acceptor substrate 
with one or two glucose residues in a divalent metal ion dependent manner. The 
products of R707 catalysis featured α1,6 or β1,6 linkages as well as α1,4 linkages. A 
glycosyltransferase forming both alpha and beta glycosidic bonds has not been 
described before. Mimivirus L373 was identified as specific UDP-N-acetylglucosamine 
hydrolase with glycosyltransferase like characteristics. L373 activity was divalent metal 
ion dependent. We could rule out a number of activities for the other four putative 
glycosyltransferase candidates. Co-infection of amoeba with mimivirus and amylose or 
dextran induced a dose-dependent decrease of infection rate further underlining the 
importance of glycan glycan-binding protein interaction in mimivirus infection. 
The results of this work gives further evidence for a mimivirus specific, host-
independent glycosylation machinery and the necessity for mimivirus to invest energy 
in the production of virus specific glycans. The catalysis of R707 resulting in products 
with different configurations promote the peculiarity of mimivirus. Future in depth-
study of mimivirus glycosyltransferase catalysis might give valuable insights on 
mechanisms of glycosylation in general. 
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ZUSAMMENFASSUNG 
Die Entdeckung des Riesenvirus Mimivirus 2003 stellte klassische Dogmen der 
Virologie in Frage. Viren wurden bis dato als kleine, filtrierbare Stoffe eingestuft, die 
stark von ihrem Wirt abhängig sind und eine minimale Anzahl von Genen mitbringen. 
Mimiviruspartikel haben einen Durchmesser von 500 nm und sind damit grösser als 
viele parasitäre oder frei lebende Mikroben. Ausserdem ist das Genom von Mimivirus 
mit einer Grösse von 1.2 MBp und 1‘262 mutmasslichen Genen riesig. Viele dieser Gene 
wurden noch nie in Viren beschrieben und vorgängig als exklusive Gene des zellulären 
Lebens gesehen. Einige Beispiele sind tRNA-Synthasen, DNS-Reparaturenzyme, 
Chaperone und Stoffwechselenzyme. Ausserdem enthält das Genom von Mimivirus 
mehrere Gene, die eine scheinbar voll funktionsfähige Glykosylierungsmaschinerie 
bilden. Konventionelle Viren nutzen die Glykosylierungsmaschinerie ihres Wirts. Die 
einzige heute bekannte Ausnahme bildet Paramecium bursaria Chlorellavirus. Dieses 
Riesenvirus kodiert funktionelle Glykosyltransferasen, welche für die Synthese von 
virusspezifischen Glykanen zum Beispiel auf dem viralen Kapsidprotein verantwortlich 
sind. Die Synthese von mehreren Nukleotidzuckern, nämlich UDP-N-
acetylglucosamine, UDP-Rhamnose und UDP-Viosamine, in Mimivirus ist bereits 
beschrieben. 2011 wurde eine erste, funktionelle Glykosyltransferase in Mimivirus 
charakterisiert. Mimivirus L230 kodiert ein bifunktionales, Kollagen modifizierendes 
Enzym, welches Lysine hydroxyliert und diese anschliessend glukosyliert. Über die 
weiteren elf mutmasslichen Glykosyltransferasen in Mimivirus ist bis heute nichts 
bekannt. In Rahmen dieser Arbeit wurden die Funktionalität von sechs der elf 
mutmasslichen Glykosyltransferasen und deren mögliche Rolle in der Infektion von 
Amöben untersucht. 
Die sechs Glykosyltransferasen wurden als rekombinante Proteine in E. coli exprimiert. 
Die Expression und Aufreinigung der Proteine war in fünf von sechs Fällen erfolgreich, 
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nämlich im Fall von L193, R139, R363, R654 und R707. Der sechste Kandidat, L373, 
wurde in Spodoptera frugiperda Sf9 Zellen exprimiert. Um eine Idee von der 
Funktionalität der Glykosyltransferasekandidaten zu bekommen, analysierten wir die 
Proteinsequenzen mit Hilfe von bioinformatischen Programmen. Die so gewonnenen 
Resultate in Kombinaten mit schon bekannten Daten über die Monosaccharid-
komposition und O-Glykanstrukturen von Mimivirus nutzten wir für gezielte Tests der 
Glykosyltransferaseaktivität in vitro. Mimivirus R707 wurde als Glykogenin-1 Homolog 
identifiziert, welches Glukoseakzeptorsubstrate mit einem oder zwei Glukoseeinheiten 
verlängerte. Die Produkte der R707 Katalyse hatten sowohl β1,6 als auch α1,6 und α1,4 
Bindungen. Die Katalyse war Metallionen abhängig. Eine Glykosyltransferase, die 
Alpha- und Betabindungen formt, wurde bis anhin noch nicht beschrieben. Mimivirus 
L373 wurde als spezifische UDP-N-acetylglukosaminylhydrolase mit Glykosyl-
transferaseeigenschaften identifiziert. Die Aktivität von L373 war Metallionen abhängig. 
Für die anderen mutmasslichen Glykosyltransferasen konnten wir mehrere mögliche 
Aktivitäten ausschliessen. Die parallele Infektion von Amöben mit Mimivirus und 
Amylose oder Dextran führte zu einer konzentrationsabhängigen Reduktion der 
Infektionsrate. Dieses Resultat unterstreicht die Wichtigkeit der Interaktion von 
Glykanen und Glykan bindenden Proteinen während der Mimivirusinfektion. 
Im Rahmen dieser Arbeit wurden weitere Beweise dafür erbracht, dass Mimivirus eine 
spezifische, wirtsunabhängige Glykosylierungsmaschinerie besitzt und es für Mimivirus 
lohnenswert ist, Energie in eine eigene Glykosylierungsmaschinerie zu investieren. R707 
Katalyse resultierte in Produkten mit verschiedenen Konfigurationen und unterstreicht 
damit Eigentümlichkeit von Mimivirus. Zukünftige Untersuchungen der Katalyse-
mechanismen von mimiviralen Glykosyltransferasen könnten wertvolle Erkenntnisse 
über Mechanismen von Glykosyltransferasen im Allgemeinen geben. 
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LIST OF ABBREVIATIONS 
Aa amino acid 
Amp ampicillin 
AP Acanthamoeba polyphaga 
Asn asparagine 
BLAST basic local alignment search tool 
BSA bovine serum albumin 
CAZY carbohydrate active enzyme database 
CID-MS collision-induced dissociation mass spectrometry 
CRISPR clustered regularly interspaced short palindromic repeats 
CroV Cafeteria rhoenbergensis virus 
DMSO dimethylsulfoxide 
DQF-COSY double quantum filtered correlated spectroscopy 
DTT dithiothreitol 
ER endoplasmic reticulum 
ESI-MS electrospray ionization mass spectrometry 
Fuc fucose 
Gal galactose 
GC-MS gas chromatography-mass spectrometry 
Glc glucose 
GlcN glucosamine 
GlcNAc N-acetylglucosamine 
GlcNAc N-acetylglucosamine 
GYG1 glycogenin-1 
HA hemagglutinin 
HCD-MS higher-energy collisional dissociation mass spectrometry 
HexNAc N-acetylhexosamine 
HIV human immunodeficiency virus 
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HMBC heteronuclear multiple bind correlation 
HPAEC-PAD high-performance anion-exchange chromatography with pulsed 
amperometric detection 
HSQC heteronuclear single quantum coherence 
Hyl hydroxylysine 
Kan kanamycin 
LPS lipopolysaccharide 
MALDI-MS matrix-assisted laser desorption/ionization mass spectrometry 
Man mannose 
NCLDV nucleocytoplasmic large DNA virus 
Neo neomycin 
NMR nuclear magnetic resonance 
ORF open reading frame 
PBCV Paramecium bursaria chlorella virus 
PBS phosphate buffered saline 
Phyre2 protein homology/analogy recognition engine v 2.0 
pNP 4-nitrophenyl 
Rha rhamnose 
ROESY rotating frame Overhauser enhancement spectroscopy 
SEM scanning electron microscopy 
TEM transmission electron microscopy 
TOCSY two-dimensional nuclear magnetic resonance spectroscopy 
UDP uridine diphosphate 
VF virus factory 
Vio viosamine 
Xyl xylose 
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INTRODUCTION 
In the past decade many members of a new, exciting class of viruses were discovered. 
These so-called giant viruses represent a curiosity in nature and their discovery 
challenges the dogma that viruses are small, filterable agents which fully depend on 
their hosts. Giant viruses harbor a variety of genes never seen in viruses before. Giant 
viruses can replicate with only small dependence on their hosts. Acanthamoeba polyphaga 
mimivirus was the first member of giant viruses to be discovered and has been their 
model organism ever since. Amongst its many unusual genes mimivirus encodes its 
own glycosylation machinery comprised of several nucleotide sugar synthesizing and 
modifying enzymes, and eleven genes that share structural similarity with prokaryotic 
and eukaryotic glycosyltransferases. Comprehension of the glycosylation machinery of 
mimivirus will contribute to understanding the role of glycosylation in giant virus 
infection and replication. 
ACANTHAMOEBA POLYPHAGA MIMIVIRUS 
DISCOVERY 
Acanthamoeba polyphaga mimivirus was originally discovered after a pneumonia follow-
up study in 1992. Mimivirus was isolated from water from a cooling-tower in England 
and thought to be a small Gram-positive bacterium named Bradfordcoccus (1). After 
“Bradfordcoccus” was studied within its natural host and after failed amplification of a 
16S rRNA, the thought to be bacterium revealed virus characteristics. In electron 
microscopy studies mimivirus presents an icosahedral capsid with a diameter of 400 nm 
surrounded by 140 nm long protein fibers (Figure 1C). Oligosaccharide coating of the 
fibers is dense and likely explaining the positive Gram-staining of mimivirus particles. 
Bradfordcoccus was renamed mimivirus, short for microbe mimicking virus (2). 
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PARTICLE STRUCTURE 
The icosahedral capsid of mimivirus is covered with heavily glycosylated surface fibers. 
These fibers commonly share the same length and are attached to anchor proteins. An 
approximately 25 kDa protein head group is attached to each fiber (Figure 1A/B/D). 
Surface fibers are produced independently of the virus particles and attached to the 
naked virion in a later step. Between the base of the surface fibers and the capsid protein 
a layer of connecting material is found. This anchor layer is seen as more or less regular, 
closely packed array of protein units of similar size. The anchor proteins protrude 3-4 
nm above the capsid surface and reside in the depressions of the capsid mesh (Figure 
1A/B/F). There are more than 3’000 fiber anchor proteins found on the surface of one 
mimivirus particle and each anchor protein allows the binding of multiple surface 
fibers. The major capsid protein of mimivirus forms an open network with a honeycomb 
structure of alternating hexagonal rings and depressions (Figure 1E). On each virus 
particle one five-fold vertex is occupied by a so-called “stargate”. The stargate allows 
delivery of mimivirus DNA into the host cytoplasm. The stargate arms are not coated 
with anchoring proteins. Each of the five arms is 250 nm long, 50 nm wide and 
protrudes above the capsid by 20 nm (Figure 1A/B/F). No capsid protein lies beneath the 
arms of the stargate. Only little substructure is found on the surface of the stargate arms 
and the arms are very resistant to proteases. The stargate is closed by a protein plug. 
Upon opening some of the arms are shed and the five capsid triangles fold back 
allowing the interior sac to emerge. The interior sac is composed of host derived lipid 
bilayer membrane and contains the viral DNA. With a diameter of 340 nm the interior 
sac has a spherical volume of 2.1 x 107 nm3. Packing of the 1.2 Mbp DNA in this volume 
would result in a packing density of 0.06 nm3/ bp, which is relatively low. This allows 
the accommodation of bound and unbound protein in the interior sac. The DNA is not 
twisted around itself or tightly bundled but present as a single strand with loops. The 
DNA is highly associated with proteins of various sizes and shapes (Figure 1A/B/G). 
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Mimivirus DNA, DNA associated proteins, and the membrane sac occupy 65% of the 
capsid volume. The inside surface of the capsid is coated with a near continuous layer of 
proteins or a lipid membrane associated with proteins. The remaining space between 
the capsid and the interior sac is filled with additional material. After the disruption of 
virions fibers emerge that cannot be assigned as being DNA or RNA. These fibers are 
usually organized into cables, bundles, or coils. A single fiber has a diameter of 1 nm 
and a prominent 7 nm periodicity of dark and light which indicates a helical structure. 
The fibers form many stranded ribbons with transverse 7 nm periodic bands. The 
ribbons are flexible and form coils. The coils are not branched and not associated with 
other proteins. The fiber coils are hundreds of nm long and their origin is not known 
(Figure 1A/B/H) (3). 
 
Figure 1 Mimivirus structures (adapted from (3-5)): A. and B. Schematic cross-section of 
mimivirus perpendicular to the fivefold axis of the particle and schematic top view of mimivirus 
with its prominent stargate (purple). From exterior to interior (A) or clockwise (B): head proteins 
(black) of surface fibers (green) attached to anchor protein (blue spheres) covering the capsid 
lattice (red spheres). Underneath the capsid an additional layer of protein (or a lipid membrane 
Introduction 
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studded with proteins) is found (yellow spheres). Between the surface of the capsid and the 
lipid bilayer (light green) fibers of intermediate length (orange) are seen. Inside the membrane 
are the genomic DNA associated with proteins (green) and other proteins not directly bound to 
the DNA (pink). C. Isolated mimivirus particle. Scale bar 200 nm. D.-H. Atomic force 
microscopy pictures of various mimivirus structures. D. Single mimivirus surface fibers with 
their head proteins and oligosaccharide coat. E. Mimivirus capsid protein forming a honeycomb 
network. F. Mimivirus stargate rising above the capsid protein mesh. Fiber anchor proteins 
marked with white arrows. G. Mimivirus DNA that is heavily associated with various proteins. 
H. Irregular networks and ribbons of fibers. 
GENOME ORGANIZATION 
The double-stranded DNA genome of mimivirus has a length of 1.2 Mbp (GenBank 
Accession number: NC_014649.1) and contains 1’262 putative open reading frames (nos) 
of which 979 are expected to be protein-coding genes, 6 tRNAs, and 33 ncRNAs (6). The 
linear genome contains two inverted repeats of 900 nucleotides near the termini. The 
DNA consists of 72% A+T. The gene distribution amongst the two genome strands is 
similar (450 on “R” and 461 on “L” strand, short for right and left strand) (7). Mimivirus 
contains many ORFs previously identified in other members of nucleocytoplasmic large 
DNA viruses (NCLDVs), yet a lot of genes were never identified in viruses before. It is 
therefore postulated that mimivirus represents a first member of Mimiviridae, a new 
family within the NCLDV (8). The unique genes of mimivirus encode proteins involved 
in protein translation (e.g. tRNA-like genes, aminoacyl tRNA synthetases, translation 
initiation factors, and peptide chain release factor), DNA repair (e.g. formamido-
pyrimidine-DNA glycosylase, UV-damage endonuclease, enzymes involved in DNA 
mismatch repair), topoisomerases, chaperones (e.g. heat shock 70-kD, peptidylprolyl 
isomerase, and ion domain protease), and new enzymatic pathways (e.g. genes involved 
in glutamine metabolism, glycosyltransferases, and lipid-manipulating enzymes) (Table 
1) (7). Some of these novel virus genes were classified as hall-mark genes for cellular 
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organisms. This makes it especially interesting to study the behavior of mimivirus in its 
host Acanthamoeba polyphaga (AP). 
Table 1 Selection of new features identified in mimivirus genome (adapted from (7)) 
ORF no. Definition/putative function Comment 
R663 Arginyl-tRNA synthetase Translation 
L124 Tyrosyl-tRNA synthetase Translation 
L164 Cysteinyl-tRNA synthetase Translation 
R639 Methyonyl tRNA synthetase Translation 
R726 Peptide chain release factor eRF1 Translation 
R624 GTP-binding elongation factor eF-Tu Translation 
R464 Translation initiation factor SUI1 Translation 
L359 DNA mismatch repair ATPase MutS DNA repair 
R693 Methylated-DNA-protein-cysteine methyltransferase DNA repair 
R406 Alkylated DNA repair DNA repair 
L687 Endonuclease for the repair of UV-irradiated DNA DNA repair 
L254 
L393 
Heat shock 70-kDa Chaperonin 
L605 Peptidylprolyl isomerase Chaperonin 
R418 NDK synthesis of nucleoside triphosphates Metabolism 
R475 Asparagine synthase (glutamine hydrolyzing) Metabolism 
R565 Glutamine synthetase (Glutamate-amonia ligase) Metabolism 
R689 N-acetylglucosamine-1-phosphate, uridyltransferase Polysaccharide 
synthesis 
L136 Sugar transaminase, dTDP-4-amino-4,6-
dideoxyglucose biosynthesis 
Polysaccharide 
synthesis 
L780 dTDP-4-dehydrorhamnose reductase Polysaccharide 
synthesis 
Introduction 
15 
REPLICATION CYCLE 
The necessary particle diameter for phagocytosis in Acanthamoeba is 0.6 μm or larger (9). 
Mimivirus infection is initiated by phagocytosis, mediated by actin protrusions resulting 
in phagosome-enclosed virions (Figure 2A) (4, 10). After lysosomal fusion the stargate 
opens allowing viral capsid to fold back (Figure 2B). Stargate opening enables 
membrane fusion between the phagosome and the inner membrane sac of mimivirus 
generating a large portal through which mimivirus genome content is released (10, 11). 
The penetration of the cytoplasm is followed by the disappearance of mimivirus for 
about two hours. After this eclipse phase the virus factory (VF), a structure within the 
cytoplasm of AP where mimivirus replication takes place, begins to occur (Figure 3). 
The VF demands for highly ordered trafficking of multiple viral proteins, that are 
expressed in the host cytoplasm (11). Within six hours the VF takes up a large volume of 
the amoebal cytoplasm (Figure 3 and Figure 2D). AP mitochondria are spatially 
associated with the VF, reflecting the need of mimivirus for energy (11). Six to nine 
hours post-infection the late phase of mimivirus replication takes place accompanied by 
icosahedral procapsid undergoing DNA packaging (Figure 2C). It is postulated that 
stargate formation occurs at an early stage of viral assembly. Biogenesis of the internal 
membrane sac is initiated by fusion of multiple small vesicles derived from host 
endoplasmic reticulum (ER) finally forming large single-layered membranes (Figure 2E). 
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Figure 2 Important steps of mimivirus life cycle (adapted from (11)). A. SEM of mimivirus 
entry into amoeba via phagocytosis mediated by actin protrusions (arrowhead), scale bar 2 μm, 
zoom in 400 nm B. Extracellular mimivirus particle revealing the structure of the stargate five-
fold opening and the interior membrane sac, scale bar 100 nm C. TEM of cytoplasmic virus 
factory depicting three distinct assembly zones. Scale bar 500 nm D. SEM of viral factory 
isolated 8 h post infection. Scale bar 500 nm E. Tomogram slice of multi-vesicular membrane 
structures generated at the periphery of mimivirus factory serving as source for the viral 
internal membrane layer. Scale bar 50 nm F. Tomogram slice of capsid undergoing DNA 
packaging with the packaging portal (green arrowhead) on the distal site of the stargate (red 
arrowhead). Scale bar 100 nm 
DNA packaging in pre-assembled capsids takes place at the distal site of the stargate, 
meaning DNA exit and packaging proceed through different portals, a unique feature 
amongst genome translocation processes and one of the features separating mimivirus 
from other NCLDV (10) (Figure 2F). 
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Figure 3 Mimivirus replication cycle in Acanthamoeba polyphaga (AP). After phagocytosis by 
AP, mimivirus (MV) disappears during an eclipse phase. After three hours the virus factory (VF) 
starts to appear. The VF expands within the following nine hours taking up more space in the 
host cytoplasm as MV is replicating. Finally AP bursts open releasing new MV particles. Nuc = 
AP nucleus. 
NUCLEOCYTOPLASMIC LARGE DNA VIRUSES 
As mentioned above, after its discovery and sequencing, mimivirus was classified as 
first member of the family of Mimiviridae within the monophyletic group of NCLDVs. 
Some other Mimiviridae family members discovered in the following years are 
Megavirus chilensis (12), A. castellanii Mamavirus (13), Moumouvirus Monve (14), and 
Cafeteria rhoenbergensis virus (15) (see below). NCLDVs unite 7 families of viruses: 
Poxviridae, Iridoviridae, Ascoviridae, Asfarviridae, Marseilleviridae, Phycodnaviridae, 
and Mimiviridae, plus the recently discovered, unclassified Pandoraviruses and 
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Pithoviruses (Figure 4) (16). An official taxonomic rank was proposed to be assigned to 
NCLDVs: the order of “Megavirales” (17). 
 
Figure 4 Schematic representation of major members of NCLDV families known to date 
(adapted from (18)). Green: Capsid protein. 
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NCLDVs feature a double-stranded DNA genome and replicate either exclusively in the 
cytoplasm or start their replication in their host’s nucleus and finish their life cycle in the 
cytoplasm (Table 2). NCLDVs infect a wide range of hosts (Table 2). The common 
ancestor of the NCLDVs contains a conserved set of 47 core genes. In 2009, an analysis of 
45 annotated proteomes of NCLDVs partitioned 9’261 of the 11’468 viral proteins in 
1’445 clusters of probable orthologs. Amongst these 1’445 clusters of orthologs 1’268 
clusters are family specific. The other 177 clusters of orthologs contain proteins from two 
or more NCLDV families. These widespread clusters of orthologs consist of genes 
encoding key functions of viral replication and morphogenesis (19). Most NCLDVs have 
capsid proteins composed of a jelly-roll fold, which is composed of a wedge-shaped, 
eight-stranded, anti-parallel β-barrel. NCLDVs have an internal membrane sac 
containing the viral DNA (20). 
Table 2 Features of the NCLDV families (adapted from (21)) 
Virus family Host Genome 
size range 
(kb) 
Genome 
structure 
Replication 
site 
Asfarviridae Mammals 170 Linear Cytoplasm 
Ascoviridae Insects 150-190 Circular Nucleus and 
cytoplasm 
Iridoviridae Insects, cold-blooded 
vertebrates 
100-220 Linear Nucleus and 
cytoplasm 
Phycodnaviridae Green-algae, algal 
symbionts of 
paramecia and hydras 
150-400 Linear/ 
circular 
Nucleus and 
cytoplasm 
Poxviridae Insects, reptiles, birds, 
mammals 
130-380 Linear Cytoplasm 
Mimiviridae Acanthamoeba, 
probably also algae 
700-1’200 Linear Cytoplasm 
Marseilleviridae Acanthamoeba, 
probably also algae 
370 Circular Nucleus and 
cytoplasm 
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Putative family 
including 
Pandoravirus (22) 
Acanthamoeba 1’900-2’500 Linear Nucleus and 
cytoplasm 
Pithovirus 
sibericum (23) 
Acanthamoeba 610 Circular Cytoplasm 
 
ASFARVIRIDAE 
Asfarvirus is an enveloped virus with an icosahedral capsid and a nucleoprotein 
complex (Figure 4). The only member of Asfarviridae causes African swine fever in 
domestic pigs and their relatives. The main symptom is hemorrhagic fever with a 
mortality rate of up to 100%. There is no species known to infect humans (24). 
ASCOVIRIDAE 
Ascoviridae are enveloped viruses with an internal core consisting of an intra-capsid 
lipid membrane and an inner particle (Figure 4). They are bacilloform, ovoid or allantoid 
and infect mainly invertebrates. Ascoviridae evolved from Iridoviridae or from 
Phycodnaviridae. Ascoviruses show some unusual features: cell infection induces the 
development of apoptotic bodies that are then used for viral assembly (25). 
IRIDOVIRIDAE 
Iridoviridae consist of an outer capsid, an intermediate lipid membrane and a central 
core containing DNA-complexes. The virions have an icosahedral form (Figure 4). Irido-
viridae infect a broad-range of invertebrates and cold-blooded vertebrates. A prominent 
member is ranavirus infecting amphibians and being the second most widespread 
infectious disease of amphibians (26). 
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PHYCODNAVIRIDAE 
Phycodnaviridae contain an inner lipid membrane and have an icosahedral capsid 
structure (Figure 4). They infect marine and freshwater algae, having an impact on 
geochemical cycling and weather patterns (27). An interesting member is Paramecium 
bursaria chlorella virus (PBCV), the pioneer amongst viruses with genomes larger than 
300 kb (28), which also encodes its own glycosylation machinery (see below) (29). 
Phycodnaviridae evolved from Iridoviridae (27). 
POXVIRIDAE 
Poxviridae are enveloped viruses which have a distinct, brick-shaped form originating 
from the outer membrane layer formed by the host’s ER (Figure 4). Poxviruses produce 
two types of infectious particles, mature virions and extracellular virions (30). Famous 
representatives are vaccinia virus and the small pox virus. The world’s first successful 
antiviral vaccine was developed against smallpox virus by using vaccinia virus, a close 
relative to poxvirus from horse and cow, as immunogen (31). 
MARSEILLEVIRIDAE 
Marseillevirus, the first member of this family, was discovered in 2007. Marseilleviridae 
have an icosahedral capsid and encode approximately 500 proteins (Figure 4). The 
family includes minimum 17 members, of which 14 are unassigned. The most prominent 
members are AP Marseillevirus and Acanthamoeba castellanii Lausannevirus (32-34). 
Antibodies against marseilleviruses have been found in the blood of asymptomatic 
humans, raising the question, whether marseilleviruses might be pathogenic in humans 
(34). 
PANDORAVIRUSES 
Pandoraviruses are the biggest viruses discovered to this point. Their genomes range 
from 2.5-2.8 Mbp. The particles are amphora-shaped (Figure 4). The first two members 
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discovered were Pandoravirus salinus, found in Chile and Pandoravirus dulcis 
discovered in a fresh-water pond near Melbourne (22). 
PITHOVIRUS SIBERICUM 
Pithovirus sibericum was isolated from more than 30’000 year old Siberian permafrost. 
The virus shows Pandoravirus-like morphology and size, but its genome is more similar 
to Iridoviruses and marseilleviruses and with 600 kb rather small in comparison to the 
size of the virion (Figure 4) (23). 
MIMIVIRIDAE 
Mimiviridae are classified in two groups, whereof group 1 is divided in three lineages 
(A, B, C) (Figure 5). Lineage A contains mimivirus itself plus Mamavirus, Sambavirus, 
and others like Terra2 (35). Mamavirus was originally isolated from water from a 
cooling tower in Paris in 2008. The Mamavirus genome is slightly bigger than the 
genome of mimivirus. The genomes are highly similar but show some divergences 
towards the termini. The Mamavirus genome also contains some unique genes like a 
small regulatory polyA polymerase subunit that is similar to poxvirus genes (13). 
Sambavirus together with its virophage was discovered in Rio Negro River in Brazil in 
2014. The genome of Sambavirus is about 50 kbp larger than the mimivirus genome (36). 
Terra2 was isolated from soil from Marseille (37). Moumouvirus is a member of lineage 
B (35). Moumouvirus was isolated from a cooling tower in southeastern France (14). 
Several viruses form lineage C: Megavirus chilensis, Courdo7, Courdo11, Terra1, 
Montpellier, and others (35). Megavirus was isolated from ocean water off coast of 
Chile, but it is capable of infecting fresh water Acanthamoeba. The Megavirus genome is 
slightly bigger than the mimivirus genome and it encodes three additional aminoacyl-
tRNA genes (12).Terra1, like Tera2, was isolated from soil sample collected in Marseille 
in 2009 (37). More and more family members are being discovered over time (38-41). 
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Figure 5 Groups and lineages within the family of Mimiviridae (A) compared in genome and 
particle size (B). 
Group 2 within the family of Mimiviridae is represented by a more distant relative of 
mimivirus, Cafeteria rhoenbergensis virus (CroV). Less than one third of the CroV genes 
have homologs in mimivirus. CroV was isolated in 2010 from a coastal water sample 
collected off Texas in the early 1990ies (15). 
VIROPHAGES OF GIANT VIRUSES 
When Mamavirus was discovered co-infection of the giant virus with a smaller, 
icosahedral virus was observed. The virophage sputnik has an 18-kbp double-stranded, 
circular genome encoding 21 proteins (42). Sputnik cannot multiply in AP but rather 
hijacks the virus factories formed by Mamavirus (43). Other virophages of giant viruses 
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were discovered such as Mavirus which is associated with CroV. Mavirus is a dsDNA 
virus with a 19 kb genome encoding 20 proteins (44). Comparative genomic and phylo-
genetic analyses lead to the assumption, that at least three major virophage lineages are 
associated with NCLDVs (Figure 6) (45). 
 
Figure 6 Overview over virophages of NCLDV. A. Unrooted phylogenetic tree of DNA 
packaging ATPase (45). B. Features of virophages (adapted from (45)). 
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EVOLUTION OF GIANT VIRUSES 
After the discovery of giant viruses the question about their evolutionary origin arose. 
Different features of giant viruses lead to the question, whether giant viruses might 
form a fourth domain of life. Unlike the textbook definition of a virus, the giants are 
non-filterable agents. Giant viruses are also larger in particle and genome size than the 
cells of various bacteria or archaea, parasitic or free-living. Pandoravirus and Pithovirus 
show an uncommon, asymmetric virion structure. Also genetically, the giant viruses 
show some cell-like features. Giant viruses harbor genes with no detectable homologs 
and unknown sources, some of which are encoding components of the translation and 
core transcription machinery. This led to the idea that giant viruses might have to be 
incorporated in the tree of life as fourth domain. A maximum likelihood reconstruction 
of gene gain and loss events during evolution of giant viruses indicates that each family 
evolved from viruses with smaller genomes. Recent data suggests an accordion-like 
model of giant virus evolution which involves successive steps of gene gain and gene 
losses (46) Phylogenetic analysis of 13 genes involved in translation, which are also 
widely presented in at least 2 other domains of life showed, that 12 out 13 genes are 
separated from the eukaryotic root by multiple edges. Also, these genes are often 
polyphyletic amongst different families of giant viruses suggesting that the universal 
cellular genes of giant viruses were acquired by giant viruses from their eukaryotic 
hosts at different stages of evolution (16). Numerous genes of giant viruses are ORFans. 
These genes do not have any homologs, apart from genes in closely related strains, 
others have only very few homologs. One study analyzing 1’292 phylogenetic trees not 
including the core genes of NCLDV for origin interference found that the viral genes are 
primarily of eukaryotic origin. The variation between different families of giant viruses 
was found to be huge (Figure 7). This also indicates a distinct evolutionary history for 
giant viruses and contradicts the fourth domain hypothesis. 
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Figure 7 Phylogenetic breakdown of giant virus genes (adapted from (16)). Analysis of 1’292 
phylogenetic trees of giant virus genes (excluding ORFans and genes with only few homologs 
and/or limited similarities to the detectable homologs) showing the evolutionary origin of giant 
virus genes. 
POTENTIAL PATHOGENICITY OF GIANT VIRUSES IN HUMANS 
After the discovery of Mimiviridae and other giant viruses all over the world from all 
kinds of sources it became obvious that these viruses might be a potential danger for 
humans. An analysis of the published literature in 2014 concludes that Mimiviridae and 
Marseilleviridae are potential agents of community-acquired and healthcare associated 
pneumonia. Infection with these viruses seems to be involved in poor outcome in 
patients in intensive care units. The exact mechanism underlying the induction of 
pneumonia by mimivirus remains unclear (47). Another study showed that mimivirus is 
taken up by professional macrophages, suggesting that alveolar macrophages could be a 
potential target for the propagation of mimivirus causing pneumonia (48). Several 
studies were performed with the aim to isolate giant viruses from patient’s stool 
samples. Marseillevirus was found in stool from a healthy Senegalese, mimivirus in a 
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Tunisian patient with pneumonia, and Shan virus in another Tunisian patient with 
pneumonia. In case of Shan virus 1’605 stool samples were analyzed and one probe was 
positive indicating that giant viruses are rare in human stool (49). Our group showed 
that the exposure to mimivirus collagen L71 promotes rheumatoid arthritis in mice (50). 
Also, an analysis of human sera for anti mimivirus L71 antibodies found 22% positive 
samples in rheumatoid arthritis patients in comparison to 6% positive samples in 
healthy subjects (50). Given the wide distribution of Mimiviridae/ Marseilleviridae one 
can easily assume that humans come in contact with the viruses throughout their lives. 
Mimiviridae and Marseilleviridae, however, do not seem to be a human pathogen in a 
majority of cases. 
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PROTEIN GLYCOSYLATION 
GENERAL CONCEPTS OF EUKARYOTIC PROTEIN GLYCOSYLATION 
Most plasma-membrane and secretory proteins are post-translationally modified with 
carbohydrate chains. Glycosylation is an important chemical modification and plays 
various biological roles e.g. in mediating cell-cell interactions, protein folding and many 
more. Protein glycosylation mainly takes places in the ER and in the Golgi apparatus. 
There are two important types of carbohydrate modifications of proteins resulting in the 
formation of glycoproteins: N-glycosylation and O-glycosylation (Figure 8). 
 
Figure 8 N- and O-glycosylation in animals. A. Examples for N- and O-glycosylation in animals 
(adapted from (51)). B. The three general types of N-glycosylation in a mature glycoprotein: 
oligomannose, complex, and hybrid, each with the common core Man3GlcNAc2Asn. C. Different 
types of O-glycosylation found in eukaryotes. Asn= asparagine S/ Ser= serine, T/ Thr= threonine, 
Hyl= hydroxylysine. 
In eukaryotes N-glycosylation takes place in the ER. On a consensus sequence motif, 
namely Asn-X-Ser/Thr (where X is any amino acid but proline), a large glycan core is 
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added en bloc from the lipid carrier dolichol phosphate. After proper folding the protein 
can exit the ER towards the Golgi. In the Golgi the N-glycan undergoes various 
trimming and elongation steps to form a vast variety of different oligosaccharides 
(Figure 8B) (52). The synthesis of O-glycans is initiated by the addition of a single 
monosaccharide followed by stepwise extension of the glycan. The elongation of O-
glycans mainly takes place in the Golgi apparatus. Many cytoplasmic and nuclear 
proteins that do not enter the secretory pathway gain their O-glycans in the cytoplasm. 
In O-glycosylation the sugar is added to the oxygen atom of serine, threonine, 
hydroxylysine, or hydroxyproline of a fully folded protein. There are different types of 
core structures in O-glycosylation forming different types of glycans with various 
functions (Figure 8C) (53). Glycosylation is performed by a specific class of enzymes, the 
glycosyltransferase. Glycosyltransferases are a prevalent enzyme type, found through-
out all kingdoms of life. Glycosyltransferases represent about 1-2% of genomes. To date, 
more than 245’000 genes are classified as glycosyltransferases on the Carbohydrate 
Active enZYme database (CAZY). They are grouped within 97 distinct, sequence-based 
enzyme families (EC 2.4.1.x, 2.4.2.x, 2.4.99.x, 3.1.3.x, 3.2.1.x, 3.5.1.x, 5.4.99.x) (54, 55). If a 
glycosyltransferase shares similarity in at least 100 amino acids in two different stretches 
to members of one glycosyltransferase family but not to other families this 
glycosyltransferase is assigned to that specific family with the same predicted fold (56). 
More than 90% of the sequences annotated on CAZY are uncharacterized ORFs. 
Glycosyltransferases are defined as enzymes that catalyze the transfer of sugar moieties 
from activated donor molecules to specific acceptor molecules forming a glycosidic 
bond. Usually, glycosyltransferases are highly specific in regard to substrate, acceptor, 
and the glycosidic bond they form. Glycosyltransferases can be inverting or retaining 
depending on the stereochemistry of their substrates and products (Figure 9A). Given 
the large number of sequences it is striking that two types of active folds, termed GT-A 
and GT-B, (and variants thereof) have been identified for glycosyltransferases using 
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nucleotide sugars as substrates (Figure 9B) (57). The GT-A motif consists of a single 
domain with the first 120 amino acids forming a Rossmann fold. Rossmann folds are 
usually found in proteins binding nucleotides. Within the GT-A motif the Rossmann 
fold is responsible for binding the donor sugar nucleotide. With the exception of one 
enzyme, all glycosyltransferases with a GT-A domain possess a DXD motif which is 
responsible for the coordination of a metal ion. The GT-B fold consists of two domains 
separated by a cleft which is responsible for acceptor binding. Both domains show 
elements similar to Rossmann folds, but it is the carboxy terminal domain which is 
responsible for binding of the donor nucleotide sugar. GT-B fold containing enzymes do 
not have a DXD motif and are independent of metal ions (58). 
 
Figure 9 A. Proposed reaction mechanisms for inverting and retaining glycosyltransferases 
(GTs). Single displacement mechanism in an inverting glycosyltransferase reaction forming an 
oxocarbenium-ion in the transition state. The OH-group of the acceptor (HOR) is deprotonated 
by a catalytic amino acid. The negative charge on the phosphate group can be stabilized by a 
metal ion (M2+) (GT-A enzymes) or by positive amino acids or a helix dipole (GT-B enzymes). 
The two proposed mechanisms for retaining enzymes: double displacement and SNi-like. Two 
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SN2 reactions are involved in the double displacement mechanism. First the anomeric center of 
the donor sugar nucleotide is attacked resulting in a covalent glycosyl-enzyme intermediate. 
This intermediate is attacked by a hydroxyl-group of the acceptor. In the SNi mechanism an 
interaction between the departing phosphate and the acceptor nucleophile leads to the 
formation of an oxocarbenium ion that is stabilized by the glycosyltransferase. ROH = acceptor 
substrate. R’ = donor sugar nucleotide (57). B. Ribbon diagrams of representative GT-A and 
GT-B folds. GT-A: rabbit β1-2-N-acetylglucosaminyltransferase I (PDB ID 1foa), GT-B: T4 phage 
β-glucosyltransferase (PDB ID 1j39). Bound nucleotide sugar shown in stick representation (58). 
No correlation exists between the fold and reaction stereochemistry. Both inverting and 
retaining enzymes are known for GT-A and GT-B enzymes. Inverting glycosyl-
transferase reactions are suggested to happen in a single displacement SN2 reaction 
forming an intermediate oxocarbenium-ion. The negative charge of the leaving 
phosphate group can be stabilized by a metal ion in case of GT-A enzymes or by 
positive amino acids or a helix dipole in case of GT-B enzymes. For retaining enzymes 
two mechanisms have been proposed. The double displacement mechanism involves 
two SN2 reactions. First the anomeric center of the donor sugar nucleotide is attacked 
resulting in a covalent glycosyl-enzyme intermediate. This intermediate is attacked by a 
hydroxyl-group of the acceptor. In the SNi mechanism an interaction between the 
departing phosphate and the acceptor nucleophile leads to the formation of an 
oxocarbenium-ion that is stabilized by the glycosyltransferase (Figure 9A) (57). In regard 
to kinetics, many glycosyltransferases have been shown to work in a Bi Bi sequential 
kinetic way. The donor sugar nucleotide binds before the acceptor substrate and the 
glycosylated acceptor is released before the nucleotide di- or monophosphate. This kind 
of kinetic goes in hand with the structural model in which the active site forms a deep 
pocket with the nucleotide donor sugar at the bottom and the acceptor substrate stacked 
on top (58). Usually, the donor sugar nucleotide binds the glycosyltransferase first 
inducing a conformational change. The glycosyltransferase is forming a lid over the 
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donor sugar nucleotide facilitating the binding of the acceptor substrate. This lid is 
formed by an internal disordered loop that becomes ordered when the donor sugar 
nucleotide is bound. A change in orientation and conformation of the now ordered loop 
facilitates the binding of the acceptor substrate and catalysis (56). 
VIRUS GLYCOSYLATION 
Although virus genomes usually do not encode any glycosyltransferases, structural 
proteins of viruses are often modified by both N- and O-glycosylation. Virus 
glycoproteins play diverse roles in the lifecycle of viruses. Virus glycoproteins can be 
important for host-virion binding, for entry; virus glycoproteins can serve as localization 
signals or protect virus particles from degradation and host immune response by 
forming a sugar shell masking the protein surface (Table 3). Glycosylation of virus 
envelope or surface proteins can promote proper folding and trafficking of virus 
proteins via the host’s chaperones and folding factors. Virus glycoproteins are often 
complex and show dynamic glycosylation patterns: viral evolution due to high mutation 
rates allows the adding and deletion of glycosylation sites. A well-studied example of a 
virus protein is influenza hemagglutinin (HA). The surface glycoprotein HA influences 
various processes like receptor binding, infectivity, virus release, and neurovirulence. 
HA allows influenza virus to attach and enter its host cell through sialylated receptors. 
Upon binding HA is cleaved by a cellular protease. Both binding and cleavage of HA 
are influenced by the glycosylation of the protein. Also, the release of influenza virus 
from its host cell mediated by neuraminidase is influenced by the degree of HA 
glycosylation (59). Another famous example for virus glycoproteins is the envelope 
protein of HIV-1, gp120. Gp120 is one of the most heavily glycosylated proteins found in 
nature. A large number of high-mannose (Man) N-glycans decorate the protein. Gp120 
binds to CD4 on the host cell surface. Gp120 is crucial for virus survival and immune 
evasion. A change in gp120 glycosylation alters the sensitivity of neutralizing antibodies 
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against HIV. The changing glycan shield of HIV-1 represents a mechanism for viral 
persistence despite an increasing antibody repertoire in the host (59). 
Table 3 Examples for viral protein glycan structure and function (adapted from (59)) 
Virus Protein Glycan Structure Role 
Influenza HA High Man, GlcNAc Attachment, release, glycan shield? 
HIV-1 gp120 High Man, hybrid, 
sialic acid 
Attachment, glycan shield 
Hepatitis C virus E1, 
E2 
High Man Infectivity, entry 
West Nile virus E High Man, fucose Replication, neuroinvasion 
SARS-Corona virus S, 
M 
High Man, hybrid, 
GalNAc 
Assembly, attachment 
Ebola GP High Man Infectivity 
 
To achieve glycosylation the vast majority of viruses utilize host-encoded glycosyl-
transferases located in the ER and Golgi apparatus (60). After folding and glycosylation, 
virus glycoproteins are usually transported to virus specific regions of host membrane 
by the sorting and transport mechanisms of the host cells (61). This means that the viral 
glycan pattern is host specific (Figure 10). The only strategies a virus can apply to alter 
its glycosylation pattern is either to infect a different cell type, affect the expression of 
host glycosyltransferases, or to change its own glycosylation sites through mutations. 
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Figure 10 Schematic representation of virus glycosylation and mimivirus glycosylation. 
Glycoproteins of most viruses pass through the glycosylation and secretory machinery of their 
host. Therefore the glycoproteins carry a host specific glycan pattern. Mimivirus encodes its own 
glycosyltransferases and it is highly likely that glycosylation takes place in the virus factory 
independent of the host glycosylation machinery. Thus, mimivirus glycoproteins show a virus 
specific glycosylation pattern with unusual monosaccharides and linkages. 
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Recent findings show that few viruses encode their own glycosyltransferases (Table 4) 
(62). The diverse functions of these virus encoded glycosyltransferases illustrate several 
fascinating aspects of virology. For instance T2, T4, and T6 bacteriophages have the 
ability to avoid host anti-viral mechanisms by glycosylation of their DNA and thus 
protection from host-derived endonucleases (63). Other bacteriophages confer virulence 
factors in the bacteria they invade. This mechanism plays a crucial role in the 
development of new serotypes.  
Table 4 Glycosyltransferases encoded by viruses (adapted from (63) and (29)) 
Virus Glycosyltransferase Biochemical Effect 
Bacteriophages   
T2, T4, T6 α- and β-glucosyl-
transferases 
Glycosylation of viral DNA: protection 
from host endonuclease 
Serotype 
converting 
phage 
Specific for each 
bacteriophage 
Conversion of bacterial O-antigen: 
inhibition of cell superinfection 
Host-cell serotype conversion 
Baculoviruses 
(all except XcGV 
and PhopGV) 
Ecdysteroid 
transferase 
Glycosylation of ecdysteroid hormone: 
Inhibition of insect moulting and pupation 
Chordopoxvirus α-2,3-sialyl-
transferase 
Post-translational modification of SERP-1 
Herpesviruses   
Rhadinovirus Core 2 β-1,6-N-
acetylglucosaminyl-
transferase mucin 
type 
Post-translational modification of 
structural proteins 
Chloroviruses   
Paramecium 
bursaria chlorella 
virus 
ORFs a64r, a111r, 
a114r, a222-226r, 
a328l, a473l and a546l 
Hyaluronan 
synthase 
Post-translational modifications of the 
major capsid protein Vp54 
 
Synthesis of a dense hyaluronan network 
on infected cell surface 
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Other bacteriophages confer virulence factors in the bacteria they invade. This 
mechanism plays a crucial role in the development of new serotypes. Other viruses have 
the ability to alter their host’s metabolism. For example, most baculoviruses inhibit their 
host’s moulting and pupation by glycosylating the insect hormone ecdysteroid. The 
described virus encoded glycosyltransferases are embedded in the host glycosylation 
machinery located in the ER and Golgi apparatus (63).  
Chloroviruses, members of Phycodnaviridae, use a different system of glycosylation. 
The most prominent member of chloroviruses, PBCV-1, encodes at least five putative 
glycosyltransferases as well as enzymes involved in sugar metabolism and synthesis of 
polysaccharides. PBCV-1 particles assemble in so-called virus-assembly centers and 
glycosylation of virus proteins takes places in these centers independent of the host 
glycosylation machinery (29). The major capsid protein Vp54 of PBCV-1 carries a virus 
specific N-glycan (29). This N-glycan is not attached to the canonical sequon and the 
glycan structure is atypical and more reminiscent of bacterial and archaeal glycans (64). 
The mimivirus VF is a similar intracellular structure for replication and assembly and 
the putative mimivirus glycosyltransferases lack ER signaling sequences. Hence any 
glycosylation occurring in mimivirus is likely independent of AP (Figure 10). 
GLYCOSYLATION IN MIMIVIRUS 
Glycan content and O-glycosylation 
The monosaccharide composition of mimivirus was analyzed in the past using two 
different approaches: gas chromatography-mass spectrometry (GC-MS) for analysis of 
the glycans on the surface fibers and high-performance anion-exchange 
chromatography with pulsed amperometric detection (HPAEC-PAD) for analysis of the 
total monosaccharide content. The GC-MS study identifies rhamnose (Rha), glucose 
(Glc), and N-acetyl-glucosamine (GlcNAc) as main components of mimivirus glycans. 
Low amounts of ribose, arabinose, xylose (Xyl), Man, and galactose (Gal) are also found. 
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In addition to the known sugars two unusual sugars are found, one being viosamine 
(Vio) and the other suggested to being 3-O-methyl-Vio (65). The study using HPAEC-
PAD identifies the following monosaccharides as components of mimivirus glycans: 
Rha, glucosamine (GlcN), Glc with a molar ratio of 1.9:2.6:1, and small amounts of 
fucose (Fuc) and Xyl. An unidentified monosaccharide is assigned to be methyl-Vio 
(Figure 11A) (66). The same study finds different groups of mimivirus O-glycans. Most 
mimivirus O-glycans are linear hexose polymer sequences. These linear O-glycans can 
be grouped according to their reducing end residues: di-methylated deoxy-hexose (di-
methyl-Rha), methylated deoxyhexosamine (methyl-Vio), di-methylated hexose (di-
methyl-Glc), hexose (Glc), and methylated hexosamine (methyl-GlcN). The oligohexoses 
correspond to Glc polymers. Mimivirus also has branched O-glycan structures. The 
branched O-glycans have a hexose (2-, 6-substituted glucitol) at the reducing end and 
terminal N-acetylhexosamine (residues with methyl modifications methyl-GlcNAc) and 
a terminal pentose residue (Xyl) in 3- or 4-linkage to N-acetylhexosamine (GlcNAc) 
(Figure 11B). 
 
Figure 11 Monosaccharide analysis of mimivirus proteins (A) and schematic representation of 
selected mimivirus O-glycans (B). A. mimivirus protein extract was chromatographed by 
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HPAEC-PAD: Gal was used as internal standard for quantification. Black arrow: elution 
position of Vio. Asterisk: unidentified peak. B. Selected branched (top) and linear (middle and 
bottom) mimivirus O-glycans. Circle: Glc; square: GlcNAc; square with crossline: GlcN; star: 
Xyl; Me: methyl; ol: reducing end. 
Nucleotide-diphospho-sugar synthesizing enzymes 
The mimivirus genome encodes several genes involved in the synthesis of nucleotide-
diphospho-sugars. In 2010 two enzymes were identified that are involved in the 
synthesis of UDP-Rha. R141 encodes a UDP-D-Glc-4, 6-dehydratase and L780 encodes a 
bifunctional UDP-4-keto-6-deoxy-D-Glc 3, 5-epimerase/4-reductase. The UDP-L-Rha 
synthesis pathways and enzyme properties are similar as those described for plants (67). 
Mimivirus L136 was identified as PLP-dependent sugar aminotransferase. It catalyzes 
the formation of UDP-Vio (4-amino-4, 6-dideoxy-D-Glc) from UDP-4-keto-6-deoxy-D-
Glc (65). The synthesis of UDP-GlcNAc in mimivirus involves three proteins, namely 
L619, a glutamine-fructose-6-phosphate transaminase, L316, a glucosamine-6-phosphate 
N-acetyltransferase, and R689, a UDP-GlcNAc pyrophosphorylase. The synthesis of 
UDP-GlcNAc follows a eukaryotic-like strategy, but also shares some properties with 
the prokaryotic pathway (68). The genes described above are expressed at the 
intermediate to late stage of mimivirus infection, which would go in hand with their 
possible role in posttranslational modification of structural proteins and the fibers 
covering the surface of mimivirus. Indeed, the analysis of defibered viral particles finds 
a significant reduction of all monosaccharides, with a most pronounced effect on Rha, 
Vio, and GlcNAc, which were reduced to about 10% (65). 
Glycosyltransferases 
Within the mimiviral genome, eleven genes, namely L137, L138, L142, L193, L230, L373, 
R139, R363, R654, R655, and R707, are annotated as putative glycosyltransferases on 
CAZY (54, 55). The function of one of the genes, namely L230, was described in 2009. 
Mimivirus L230 is a bifunctional enzyme hydroxylating lysine and glycosylating the 
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resulting Hyl in native mimivirus collagen acceptor substrates. The glycosylating 
domain resides in the N-terminal domain and is important for the transfer of UDP-Glc 
to polypeptide Hyl (69). Apart from L230 nothing is known about the other glycosyl-
transferases in mimivirus to date. 
Knowing that mimivirus encodes its own nucleotide sugar synthesis machinery as well 
as at least one functional glycosyltransferase, which is responsible for glycosylation of 
mimivirus protein, we aim to analyze the functionality of other putative mimivirus 
glycosyltransferases. 
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ABSTRACT 
Acanthamoeba polyphaga mimivirus is a giant virus encoding 1’262 genes among which 
many were previously thought to be exclusive to cellular life. For example, mimivirus 
genes encode enzymes involved in the biosynthesis of nucleotide sugars and putative 
glycosyltransferases. We identified in mimivirus a glycogenin-1 homologous gene 
encoded by the open reading frame R707. The R707 protein was found to be active as a 
polymerizing glucosyltransferase enzyme. Like glycogenin-1 R707 activity was divalent 
metal ion dependent and relied on an intact DXD motif. In contrast to glycogenin-1, 
R707 was however not self-glucosylating. Interestingly, the product of R707 catalysis 
featured α1,6, β1,6, and α1,4 glycosidic linkages. Mimivirus R707 is the first reported 
glycosyltransferase able to catalyze the formation of both α and β linkages. Mimivirus 
encoded glycans play a role in the infection of host amoeba. Co-infection of 
Acanthamoeba with mimivirus and amylose and chitin hydrolysate reduced the number 
of infected amoeba, thus supporting the importance of polysaccharide chains in the 
uptake of mimivirus by amoeba. The identification of a glycosyltransferase capable of 
forming α and β linkages underlines the peculiarity of mimivirus and enforces the 
concept of a host-independent glycosylation machinery in mimivirus. 
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SUMMARY STATEMENT 
We have identified the mimivirus R707 protein as paralog to glycogenin-1 with 
polymerizing glucosyltransferase activity, catalyzing the formation of α1,6, β1,6, and 
α1,4 glycosidic linkages. Mimivirus R707 is the first reported glycosyltransferase 
capable of forming both α and β linkages. 
 
KEYWORDS: giant virus / polysaccharide / glycogen / glycosylation / nuclear magnetic 
resonance 
 
SHORT TITLE: Glycogenin-1 paralog in giant mimivirus 
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ABBREVIATIONS 
CID-MS collision-induced dissociation mass spectrometry 
DQF-COSY double quantum filtered correlated spectroscopy 
ESI-MS electrospray ionization mass spectrometry 
Gal galactose 
GC-MS gas-chromatography mass spectrometry 
Glc glucose 
GlcNAc N-acetylglucosamine 
GYG1 glycogenin-1 
HCD-MS higher-energy collisional dissociation mass spectrometry 
HexNAc N-acetylhexosamine 
HMBC heteronuclear multiple bind correlation 
HSQC heteronuclear single quantum coherence 
MALDI-MS matrix-assisted laser desorption/ionization mass spectrometry 
NMR nuclear magnetic resonance 
PBCV-1 Paramecium bursaria chlorella virus 
pNP 4-nitrophenyl 
Rha rhamnose 
ROESY rotating frame Overhauser enhancement spectroscopy 
TOCSY two-dimensional nuclear magnetic resonance spectroscopy 
UDP uridine diphosphate 
Vio viosamine 
Xyl xylose 
 
  
Manuscript I: Glycogenin-1 paralog in giant mimivirus 
49 
INTRODUCTION 
The giant Acanthamoeba polyphaga mimivirus is a member of the expanding family of 
Mimiviridae, belonging to the monophyletic group of nucleocytoplasmic large DNA 
viruses. The genome of mimivirus consisting of 1.2 Mbp and encoding 1’262 genes has 
been described in 2003 (1). The icosahedral mimivirus particle is 400 nm in diameter and 
covered with 140 nm long glycosylated protein fibers (2). Many mimivirus genes are 
unusual for viruses as they code for genes typical of cellular life, such as tRNA 
synthases, DNA repair factors, chaperones, and metabolic enzymes (3). Interestingly 
mimivirus encodes multiple genes possibly composing a functional glycosylation 
machinery.  
Virus glycoproteins are associated with host-virion binding, virus entry, as for example 
hepatitis C virus E1/E2, and host-immune evasion as HIV gp120 (4). Glycosylation of 
virus envelope or surface proteins can promote proper folding, trafficking, and stability 
of virus proteins, such as for example in influenza virus hemagglutinin (4). In contrast to 
giant viruses conventional viruses hijack the glycosylation machinery of their host and, 
with few examples, do not encode glycosyltransferases or other genes involved in 
glycosylation (4). A giant virus encoding its own glycosylation machinery is found in 
the family of Chloroviruses. Paramecium bursaria chlorella virus (PBCV-1), a member of 
Phycodnaviridae that infects unicellular green algae, encodes at least five putative 
glycosyltransferases as well as multiple enzymes involved in sugar metabolism (5). The 
major capsid protein Vp54 of PBCV-1 carries a virus specific N-glycan that is added to 
the protein independently of the host’s ER and Golgi pathway (5). This N-glycan is not 
attached to the canonical sequon and the glycan structure is atypical and more 
reminiscent of bacterial and archaeal glycans (6). 
In mimivirus the biosynthetic pathways of three nucleotide sugars are well 
characterized. Mimivirus synthesizes UDP-viosamine (Vio), UDP-rhamnose (Rha), and 
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UDP-N-acetylglucosamine (GlcNAc) independently of its host Acanthamoeba polyphaga 
(7-9). These nucleotide sugar donors reflect the monosaccharide composition of 
mimivirus, given that GlcNAc, Rha, and Vio are major carbohydrates isolated from 
mimivirus particles in addition to glucose (Glc) (8, 10). The analysis of the O-glycan 
content of mimivirus shows various glycan structures demanding for 
glycosyltransferases with different functionalities. Mimivirus proteins are glycosylated 
with linear O-glycans consisting of hexose polymers of variable length. Also branched 
O-glycans have been identified, which consist of a hexose at the reducing end, a 
terminal N-acetylhexosamine (HexNAc) residue on one branch and a terminal pentose 
residue linked to HexNAc on the second branch (10). 
Analysis of the mimivirus genome suggests that in addition to the nucleotide-
diphospho sugar synthesizing machinery mimivirus encodes at least 11 putative 
glycosyltransferases (3). These putative glycosyltransferases share sequence similarities 
with archaeal, bacterial, and eukaryotic glycosyltransferases. For example, the 
mimivirus L230 gene encodes a bi-functional collagen-modifying enzyme structurally 
similar to PLOD3 lysyl hydroxylase and GLT25D1 galactosyltransferase of animal origin 
(11). Another mimivirus protein, R707, is structurally related to glycogenin-1 (GYG1), 
which initiates glycogen biosynthesis in animals. Despite this similarity, R707 unlikely 
mediates glycogen formation in mimivirus, but may be involved in the assembly of 
polysaccharide decorating the virus capsid. The present study characterizes the 
glycosyltransferase activity of mimivirus R707 and the importance of polysaccharides in 
the infection of amoeba by mimivirus. 
EXPERIMENTAL/ MATERIALS AND METHODS 
Expression and purification of recombinant R707 protein – Recombinant R707 was expressed 
in Escherichia coli BL21 De3 (Novagen, Nottingham, UK) as His10-fusion protein in 
pET16b (Merck, Billerica, MA). Viral DNA was purified using phenol/chloroform (Roth, 
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Karlsruhe, Germany). The DNA sequence corresponding to mimivirus R707 (RefSeq ID 
NC_014649.1) was amplified using the primers 5’-ATACTCGAGTCTTCCT-
ATGCATATGTTACAG-3’ and 5’-ATAGGATCCTTAATAAGGTAGTTTAATGTCA-3’ 
containing XhoI and BamHI restriction sites, respectively (underlined bases). Site-
directed mutagenesis of R707 was performed by QuickChange site-directed muta-
genesis (12) using primers listed in table 1. Asn position 103 was substituted for Ser, Tyr 
215 was substituted for Phe, and Lys 232 was substituted for Arg. For protein expression 
100 ml lysogeny broth containing 100 μg/ml ampicillin (Sigma-Aldrich, Buchs, 
Switzerland) were inoculated with 1 ml of overnight culture. Protein expression was 
induced with 1 mM isopropyl-β-D-thiogalactopyranoside (Biosolve, Dieuze, France) 
when bacteria reached OD600 value of 0.4. E. coli were grown at 16°C for 16 h, shaking, 
then pelleted at 6’000 x g, resuspended in 15 ml 500 mM NaCl, 20 mM Tris pH 7.4, 10% 
v/v glycine, 10 mM imidazole (MCAC10) and lysed using a French Press (Avestin, 
Mannheim, Germany). His10-tagged R707 was purified from the soluble fraction using 
100 μl Ni-Sepharose 6 Fast Flow beads (GE Healthcare, Glattbrugg, Switzerland). After 
binding to beads in MCAC10 at 4°C for 4 h, rotating, R707 was eluted in 400 mM 
imidazole (MCAC400). Purified R707 was stored at 4°C. 
Enzymatic activity – Glycosyltransferase activity was measured in 20 mM Tris-HCl pH 
7.4 containing 0.5 μl 20 μCi/ml UDP-[14C]-sugar (Perkin-Elmer, Waltham, MA), 20 μM 
UDP-sugar, 10 mM MnCl2 (Sigma-Aldrich), 1 mM DTT, 50 mM 4-nitrophenyl (pNP)-
sugar in DMSO (Sigma-Aldrich) as acceptor substrate, and 10 μg of purified R707 
protein. The UDP-sugars tested as donor substrates were UDP-Glc, UDP-GlcNAc, UDP-
galactose (Gal), and UDP-xylose (Xyl). The pNP-sugars tested as acceptor substrates 
were pNP-Glc, pNP-Xyl, pNP-Gal, and pNP-Rha (Sigma-Aldrich). Assays were 
incubated at 35°C for 4 h, then stopped by addition of ice cold 500 μl H2O, and purified 
over SepPak-C18 cartridges (Waters, Milford, MA). Samples were added to the 
cartridges, washed with 10 ml of H2O, and eluted with 5 ml of methanol (Sigma-
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Aldrich). Radioactivity was measured after addition of 10 ml of IRGASAFE scintillation 
liquid (Perkin-Elmer) in a Tri-Carb 2900TR scintillation counter (Perkin-Elmer). Self-
glucosylation of R707 was measured as described above, but without addition of pNP-
sugar acceptor substrate. After incubation assays were stopped by addition of 500 μl 5% 
trichloroacetic acid / 5% phosphotungstic acid and incubated on ice for 30 min. 
Precipitates were recovered on 1 μm glass filters (VWR, Radnor, PA) using a vacuum 
manifold and radioactivity was measured as described above. 
Product analysis of R707 glycosyltransferase assay – About 200 pmol of glycosyltransferase 
assay product were subjected to MALDI-MS analysis. MALDI-MS were acquired 
essentially as described earlier (13). For NMR analysis assay products from 250 
glycosyltransferase assays were pooled, dried, and resuspended in 300 μl DMSO. To 
remove spare pNP-α-Glc, products were purified by gel-filtration using a Superdex 
Peptide HR 10/30 (GE Healthcare) and 10% acetonitrile, 0.1% trifluoroacetic acid at a 
flow rate of 0.1 ml/min. Different product species were separated using a Hypersil C18 
column (Thermo Scientific, Waltham, MA) under the following conditions: buffer A: 
0.1% trifluoroacetic acid (Sigma-Aldrich), buffer B: 0.1% trifluoroacetic acid, 10% 
acetonitrile (Sigma-Aldrich), 30 min 97.5% buffer A/ 2.5% buffer B, 120 min gradient to 
10% buffer B, flow rate: 0.5 ml/min. Product elution was monitored at 375 nm, and 2 
min-fractions were collected. Peaks containing a sufficient amount of product were 
pooled, dried, and subjected to NMR analysis. Products were dissolved in 220 μl D2O 
and transferred into 5 mm D2O-matched Shigemi NMR tubes (Shigemi, Allison Park, 
PA). Structure elucidation of sample A and B is based on a set of 1D proton NMR, 2D 
1H-1H double quantum filtered correlated spectroscopy (DQF-COSY), 1H-1H two-
dimensional nuclear magnetic resonance spectroscopy (TOCSY) (100 ms mixing time), 
1H-1H rotating frame Overhauser enhancement spectroscopy (ROESY) (300 ms mixing-
time), 1H-13C heteronuclear single quantum coherence (HSQC) and 1H-13C heteronuclear 
multiple bind correlation (HMBC) experiments. Identification of sample C is based on 
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1D 1H and 2D 1H-13C HSQC spectra that were also recorded for the reference 
compounds, namely pNP-α-maltose (Sigma-Aldrich). All spectra were collected at 298 K 
on a Bruker AVANCE 600 MHz spectrometer equipped with a cryogenically cooled 5 
mm TCI probe and externally referenced against 4,4-dimethyl-4-silapentane-1-sulfonate 
with a 13C/1H ratio of 0.25144953 used for the indirect 13C referencing (14). Spectra were 
processed using the Bruker TopSpin 3.5 software suite. For linkage analysis of the 
products A, B, and C GC-MS experiments were done essentially as described previously 
(10). The initial oven temperature of 80°C was held for 2 min, increased by 8°C/min until 
320°C and held for 8 min. In addition,  the products A, B, and C were analyzed by 
negative-ion ESI-MS and ESI-HCD-MS/MS experiments were carried out on an Orbitrap 
Fusion mass spectrometer (Thermo Scientific), analogous to the negative ion ESI-CID-
MS/MS method described recently (15). The glycosyltransferase reaction products were 
dissolved in 50 % acetonitrile, 2 mM NH4HCO3 (Sigma-Aldrich) at a concentration of 30 
μM and 2 μl were injected to the mass spectrometer. Solvent 50 % acetonitrile, 2 mM 
NH4HCO3 was delivered by a Harvard syringe pump at a flow rate of 4 ml/min. The 
ion- transfer tube temperature was maintained at 320°C and the capillary voltage was 
maintained at – 2700 V. For MS/MS acquisition quadrupole isolation with a 2 m/z 
isolation width and HCD activation with 0 % collisional energy was used. Ions were 
detected in the Orbitrap at a resolution of 15’000 and a scan range of 50-500 m/z. The 
AGC target was set to 5 x 104 and maximal injection time to 100 ms. 
Phagocytosis competition assay – Amoeba (5 x 103) were seeded in 96-well plates in 
peptone yeast glucose broth and infected at a multiplicity of 250 with purified 
mimivirus particles together with 1 to 10 μg of amylose, chitin hydrolysate, dextran, or 
mannan (Sigma-Aldrich). Polyvinyl alcohol (Sigma-Aldrich) was used as negative 
control. Amoeba were incubated with mimivirus and polymers at 28°C for 4.5 h, and 
then fixed in 4% paraformaldehyde. Intracellular DNA including virus factories was 
stained with DAPI for 30 min. Virus factories per total number of amoeba per view field 
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were quantified using an Axiovert 200M microscope (Zeiss, Oberkochen, Germany) and 
Fiji cell counter (16). 
Statistical analysis - ANOVA with multiple comparisons was used and a P-value of P < 
0.05 was considered as statistically significant. GraphPad Prism 6 (GraphPad Software, 
Inc., La Jolla, CA) was used for statistical analysis. Results are presented as mean ± SEM. 
RESULTS 
The mimivirus R707 protein was identified as putative glycosyltransferase based on 
sequence similarity to animal GYG1, which primes glycogen synthesis by initiated self-
glucosylation (17). GYG1 transfers Glc from UDP-Glc to a conserved Tyr residue at 
position 195, then elongates this Glc residue with up to seven additional Glc units 
through α1,4-linkage, making GYG1 a retaining enzyme (17). R707 and GYG1 shared 
26% sequence identity and 42% similarity. The mimivirus R707 protein included a DXD 
motif, which aligns with the same motif in animal GYG1 proteins (Figure 1A). The DXD 
motif is typically found in glycosyltransferases utilizing nucleotide-activated sugars as 
donor substrates, and is involved in the coordination of a divalent metal ion in the 
catalytic pocket of the enzyme (18). In GYG1 Leu position 8, Thr 10, Asn 11, Tyr 14, Asp 
101, Ala 102, Asp 103, Asn 132, Gln 163, His 211, Gly 214, and Lys 217 are involved in 
the coordination of UDP-Glc. The homologous residues Asn 13, Tyr 16, Asp 101, Asp 
103, Asn 150, His 226, and Lys 232 were also found to be conserved in mimivirus R707 
(Figure 1B) (19). The pattern of sequence and motif similarity between GYG1 and R707 
suggested a common Glc polymerizing activity for both proteins. Based on BLAST 
analysis the putative glycosyltransferase domain spanned nearly the entire R707 protein 
between amino acid position 4 and 265 (Figure 1C). A 3D-model comparison of R707 
and GYG1 using PHYRE2 and SWISS-MODEL shows strong conservation around the 
DXD motif and main secondary structures. The majority of the α-helices and β-sheets of 
GYG1 from residue 1-230 align with R707 (20, 21). Both proteins show structural 
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diversity towards the C-terminus as predicted by BLAST analysis. The R707 gene is 
expressed in the intermediate and late phase of mimivirus replication, indicating a 
possible involvement of R707 in virion maturation and fiber formation (22). 
The R707 protein was expressed in E. coli as His10-fusion protein, purified by affinity 
chromatography, and glycosyltransferase activity was tested. For product purification 
pNP-α-Glc and pNP-β-Glc were used as acceptor substrates. In presence of pNP-α-Glc 
R707 showed a specific activity of 19.6 pmol/min/mg. In presence of pNP-β-Glc R707 
activity reached only 7.1 pmol/min/mg (Figure 2A). To test for a possible self-
glucosylation activity of R707, we omitted the acceptor substrate from the enzymatic 
reaction. We could not detect any self-glucosylation activity on R707 (Figure 2A). 
To assess the functionality of different residues of R707, we mutated amino acids in 
R707, which correspond to the essential residues Asp 103, Tyr 195, and Lys 217 in GYG1. 
The residue Asp 103 of R707 is part of the conserved DXD motif, Tyr 215 corresponds to 
the glucosylated Tyr residue of GYG1, and Lys 232 corresponds to a residue involved in 
the coordination of UDP-Glc in GYG1 (19). The loss of the DXD motif and of the 
coordinating Lys 232 residue abolished the glycosyltransferase activity of R707. By 
contrast, the mutation of Tyr 215 had no effect on R707 activity (Figure 2B), confirming 
the lack of self-glycosylation in the mimivirus glycosyltransferase. Like GYG1, the 
glycosyltransferase activity of R707 required the divalent cation Mn2+. R707 activity was 
decreased to 19% in absence of Mn2+, to 20% after substitution of Mn2+ with Mg2+, and to 
10% after substitution of Mn2+ with Ca2+ (Supplementary Figure 1A). In GYG1 the 
substitution of Mn2+ with Mg2+ and Ca2+ decreased glycosyltransferase activity to 5% and 
10%, respectively (19). 
To determine the substrate specificity of R707, we tested the nucleotide-sugar donors 
UDP-Glc, UDP-GlcNAc because these monosaccharides are the main carbohydrates of 
mimivirus glycans (8, 10). We also tested UDP-Gal as an epimer of UDP-Glc and UDP-
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Xyl because it is used as alternative nucleotide-sugar donor by GYG1 (17). Similarly, we 
tested the monosaccharides pNP-α-Glc, pNP-α-Xyl, pNP-α-Gal, and pNP-α-Rha as 
acceptor substrates. UDP-Glc was the only donor substrate compatible with R707 
glucosyltransferase activity (Supplementary Figure 1B). The corresponding 
glucosyltransferase activity was highest towards the α-linked Glc acceptor pNP-α-Glc, 
but R707 showed also significant glucosyltransferase activity towards pNP-α-Xyl. By 
contrast, none of the other monosaccharides tested were valid acceptor substrates for 
R707 (Supplementary Figure1 C). As a comparison, GYG1 can also use UDP-Xyl as 
donor substrate, although the transfer of Xyl blocks the elongation of the Glc polymer 
by GYG1 (17). 
To characterize the product of R707 catalysis we first subjected 200 pmol of purified 
reaction product to mass spectrometry analysis. In addition to the acceptor substrate 
pNP-α-Glc, the elongation products pNP-α-Glc2 and pNP-α-Glc3 were detected with a 
ppm error < 50 ppm (Figure 3), confirming the polymerizing activity of R707. A 
fragment spectrum of pNP-α-Glc2 confirmed the presence of the product. To analyze the 
type of glycosidic linkage catalyzed by R707, reaction products were purified by 
reverse-phase chromatography allowing a qualitative separation of the main products of 
the glycosyltransferase reaction. Two main chromatography peaks plus one additional 
peak recovered were subjected to NMR analysis (Figure 4). All other analyzed peaks 
showed a too high degree of structural heterogeneity to enable NMR analysis and 
linkage determination. The glycosidic linkages were identified from the cross peaks in 
the ROESY spectra. The rotating-frame Overhauser enhancements between the 
anomeric proton 1’ and the protons 6a/6b established the 1,6-linkage for the two main 
reaction products analyzed (Figure 5, Supplementary Figure 2). Differentiation between 
the α- and β-configuration at the anomeric centers was based on the 3J1,2 coupling 
constants. Except for the anomeric proton 1’ of sample A these couplings could be 
directly determined from the splitting of the H1 (H1’) doublets in the 1D proton 
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spectrum. For the anomeric proton 1’ of sample A, which was obscured by the HOD 
signal, this coupling was identified from the H2’/H1’ cross peak patterns in the DQF-
COSY and then extracted from the H2’ multiplet in the 1D proton spectrum. For 
comparison all the H2/H1 (H2’/H1’) COSY cross peaks are shown (Figure 5). The 
neighboring coupling constant between anomeric protons indicates their relative 
orientation in pyranose structures. In a β configuration a coupling constant of 7-8 Hz is 
observed, in an α configuration the coupling constant is around 4 Hz (23). The following 
coupling constants were obtained: sample A: 3J1,2 =3.7 Hz; 3J1’,2’ =3.7 Hz; sample B:  3J1,2=3.6 
Hz; 3J1’,2’ =8.0 Hz. The 3J coupling constants confirmed the α-configuration for product A 
and the β-configuration for product B (Figure 5). The additional reaction product C of 
R707 was also subjected to NMR analysis; a comparison of the HSQC data with the 
authentic standard indicated its identity as pNP-α-Glc(α1-4)Glc (Supplementary Figure 
3). The NMR analysis thus identified pNP-α-Glc(α1-6)Glc, pNP-α-Glc(β1-6)Glc, and 
pNP-α-Glc(α1-4)Glc as R707 reaction products. Peaks A, B, and C were further analyzed 
by GC-MS and negative ion ESI-MS/MS for linkage determination of the pNP-
disaccharides. The elution positions in the GC-MS analysis and the fragment ion 
products of the negative-ion ESI-MS identified a Glc(1-6)Glc linkage for peaks A and B 
and Glc(1-4)Glc linkage for peak C, corroborating the assignments based on NMR 
analyses (Figure 6, Supplementary Figure 4). 
Mimivirus glycans are mainly found on the heavily glycosylated surface fibers (2, 8). 
Any additional role for mimivirus glycans in a later stage of infection, however, cannot 
be ruled out. Considering the formation of linear Glc polymers bearing various linkages 
by R707, we investigated the functional significance of such Glc polymers and other 
polysaccharides in the context of mimivirus infection. Upon infection of amoeba by 
mimivirus, we detected virus factories in 77% of amoeba 4.5 h post infection (Figure 
7A). The addition of the α1-4 linked Glc polymer amylose to amoeba decreased 
mimivirus infection in a dose dependent manner, indicating that α1-4 linked Glc chains 
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are indeed required for the uptake of the virus by amoeba (Figure 7B). A similar 
inhibition of virus infection was observed by addition of β1-4 linked GlcNAc in the form 
of chitin hydrolysate. The localization of the major proportion of GlcNAc is unknown to 
date as only a small proportion of O-glycan structures contain GlcNAc even though 
GlcNAc is the major monosaccharide in mimivirus (10). By contrast, addition of the β1-6 
linked Glc polymer dextran and of the α1-4 linked mannose polymer mannan had no 
effect on mimivirus infection (Figure 7B). The competitive inhibition of mimivirus 
infection by amylose and chitin hydrolysate confirmed the importance of 
polysaccharides in the capture of mimivirus by amoeba. 
 
DISCUSSION 
We have shown that mimivirus R707 is a functional glycosyltransferase transferring Glc 
from UDP-Glc to Glc through multiple glycosidic linkages. The R707 enzyme has strict 
donor and acceptor substrate specificities and its glucosyltransferase activity depends 
on Mn2+. The characterized products of R707 reaction were pNP-α-Glc(α1-6)Glc, pNP-α-
Glc(β1-6)Glc, and pNP-α-Glc(α1-4)Glc. Infection of Acanthamoeba with mimivirus in 
presence of soluble amylose and chitin hydrolysate reduced the number of infected 
amoeba indicating a role for glycan-binding protein interactions in the infection of 
amoeba. 
This is the first report of a single-domain glycosyltransferase capable of forming both α- 
and β-glycosidic linkages. With few exceptions glycosyltransferases exhibit strict 
linkage specificities. In some unique cases glycosyltransferases exhibit flexibility 
regarding the formed glycosidic bond. Human fucosyltransferase III attaches fucose in 
either α1-3 or α1-4 linkage (24). The α-dystroglycan modifying enzyme LARGE is a bi-
functional glycosyltransferase with both xylosyltransferase and glucuronyltransferase 
activities. LARGE generates repeats of the disaccharide unit (β1-3)Xyl(α1-3)glucuronic 
acid. In contrast to R707, LARGE consists of two separate glycosyltransferase domains 
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with each domain responsible for a specific activity (25). We found 58% identity in 
amino acid residues in the catalytic pocket of GYG1 and R707. The remaining different 
residues might play a role in directing the inverting and retaining mechanism of linkage 
formation.  In inverting glycosyltransferases an active-site side chain is needed as base 
catalyst for deprotonation the incoming nucleophile of the acceptor substrate. In 
retaining glycosyltransferases a nucleophile within the active site is needed to allow a 
double-displacement reaction (26). Crystallization of R707 and further studies of the 
catalytic pocket in presence and absence of the acceptor substrate may identify the 
residues possibly serving as base catalyst and nucleophilic side chains in the transfer of 
Glc. This could explain the flexibility of R707 in mediating distinct linkages and 
configurations. 
GYG1 catalysis produces linear α1-4 Glc polymers. Branching occurs every 8-10 residues 
and is catalyzed by the glycogen branching enzyme GBE1, which catalyzes the α1-6 
addition of Glc (27). We identified pNP-α-Glc(α1-6)Glc and pNP-α-Glc(β1-6)Glc and 
pNP-α-Glc(α1-4)Glc as products of R707 catalysis. The Glc trimers we identified were 
linear chains of Glc. This goes in hand with data published on mimivirus O-glycans, 
where all identified hexose polymers were linear (10). Glycogen is the universal 
molecule for Glc storage. Glycogen synthesis has been reported for a large number of 
species, from bacteria to yeast to mammals (17, 28, 29). In mammals, glycogen synthesis 
is initiated by self-glucosylation of GYG1 in the cytosol (27, 29). In contrast to GYG1 
mimivirus R707 did not exhibit self-glucosylating activities and a disruption of the 
Tyr215 residue, corresponding to Tyr 195 in GYG1, had no influence on R707 activity. 
Mimivirus depends on energy supply from amoeba and as the virus needs immediate 
energy availability energy storage in form of glycogen hardly makes sense (30). It is 
more likely that GYG1 and R707 showed divergent evolution where GYG1 evolved to 
being the core protein of glycogen and R707 to being a glycosyltransferase involved in 
decorating other mimivirus proteins with Glc polymers. 
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An independent glycosylation machinery allows mimivirus to form virus-specific 
glycan structures. These specific glycans are probably needed for virus-host interactions 
and mimivirus infection. Mimivirus polysaccharides could mimic the cell wall of gram-
positive bacteria and thereby increase the chance of phagocytosis by Acanthamoeba (31-
33). Acanthamoeba spp. express various lectins of which some are known to be involved 
in phagocytosis of their prey (34-36). Parallel addition of amylose or chitin hydrolysate 
during mimivirus infection of amoeba reduces infection in a dose dependent manner. 
This effect is not seen in presence of dextran, mannan or poly vinyl alcohol suggesting 
specific receptor occupancy on the surface of amoeba or mimivirus resulting in reduced 
mimivirus uptake. In addition, flexible and diverse surface glycosylation might allow 
mimivirus to target different host species, as observed for Legionella pneumophila. 
Legionella pneumophila is taken up by both Acanthamoeba castellanii and Naegleria 
lovaniensis via receptor-mediated endocytosis but through binding to the different 
receptors, mannose-binding receptor on the one hand, and N-acetyl-D-galactosamine 
receptor on the other hand (36). 
The results described in this study present a basis for future investigations for a better 
understanding of the mechanism of glycosidic bond formation in glycosyltransferases. 
Our results further establish the existence of a host-independent glycosylation 
machinery in mimivirus. Furthermore, the findings presented underline the importance 
of glycan-protein interactions in mimivirus infection.  
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FIGURE LEGENDS 
FIGURE 1. Sequence homology between mimivirus R707 and eukaryotic glycogenin-1 
proteins. (A) Alignment of R707 and glycogenin-1 (GYG1) from different species using 
protein BLAST and the non-redundant protein sequences database (37, 38). The multiple 
sequence alignment of R707 and GYG1 homologs was generated using Clustal Omega 
(39). Identical residues are shaded in black (≥ 4 species) or in grey (<4 species). The DXD 
motif and catalytic tyrosine of GYG1 are marked with dashed boxes. Mutated residues 
of R707 are marked with open triangles. (B) Catalytic center of mouse Gyg1 
coordinating UDP-Glc and Mn2+ (adapted from (19)). Residues conserved in R707 are 
marked in blue. (C) Schematic representation of full-length R707 (281 amino acids long) 
and of its predicted glycosyltransferase domain spanning residues 4 to 265.  
FIGURE 2. Glycosyltransferase activity of R707. (A) Glucosyltransferase activity of 
recombinant R707 on pNP-α-Glc, pNP-β-Glc and self-glucosylation of R707 in absence 
of an acceptor substrate. (B) Glucosyltransferase activity of wildtype R707 in comparison 
to R707 including the amino acid substitutions D103S, Y215F, and K232R. Two 
independent experiments with triplicates in each instance were done. Results are shown 
as mean ± SEM. 
FIGURE 3. (A) MALDI-MS analysis of R707 assay products. 200 pmol of 
glycosyltransferase assay product were subjected to MALDI-MS analysis. The molecular 
ions of assay products are labeled with their glycan annotation. Glucose residues are 
represented by open circle. Ppm error (pNP-Glc2) = 34 ppm, ppm error (pNP-Glc3) = 15 
ppm. (B) MS2 spectrum of m/z 486.1. The inserted symbols represent the proposed 
assignments. 
FIGURE 4. R707 product purification. Approximately 300 nmol of R707 assay products 
were separated on a Hypersil C18 column. Peaks A, B, and C were subjected to further 
structural analysis by NMR. 
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FIGURE 5. Linkage analysis of R707 assay product by NMR with (A) referring to peak 
A, figure 4 and (B) referring to peak B from figure 4. Two unidentified product species 
were subjected to proton NMR TOCSY (middle panel, top) for identification of the two 
spin systems from the sugar units. Configuration between pNP and Glc (COSY, lower 
panel) and configuration between Glc and Glc (COSY, upper panel) by expansion of the 
DQF-COSY cross peaks between the anomeric proton and proton at position 2 or 2’ 
respectively allowing extraction of the 3J coupling constants and discrimination between 
the alpha (3J(1,2)~3 Hz) and beta (3J(1,2)~7 Hz) configuration. Rotating-frame Overhauser 
enhancement between aromatic proton A and anomeric proton 1 (ROESY, left panel) for 
linkage determination between pNP and Glc. Rotating-frame Overhauser enhancement 
between anomeric proton 1’ and protons 6a/6b (ROESY, middle panel, bottom) for 
linkage determination between Glc and Glc. The experiment was done twice. 
FIGURE 6. Product linkage analysis of peaks A, B, and C using GC-MS. Partially 
methylated alditol acetates (PMMA) were prepared from the R707 reaction products 
and resolved by GC-MS. Extracted chromatograms at m/z 118.061. Characteristic 
hexoses are shown. The elution positons of 2-, 3-, 4-, and 6-O-substituted PMMA were 
determined by comparison with PMMAs prepared from authentic reference 
compounds. 
FIGURE 7. Mimivirus uptake competition assay. (A) Amoeba were infected at a 
multiplicity of 250, (B) and in combination with 1 μg, 5 μg, or 10 μg of polysaccharides 
or poly vinyl alcohol (PVA). Virus factories per total number of amoeba per viewfield 
were quantified 4.5 h post infection using an Axiovert 200M microscope and Fiji cell 
counter. Two independent experiments quantifying five viewfields per condition were 
done. Results are shown as mean ± SEM. 
SUPPLEMENTARY FIGURE 1. Co-factor and substrate specificity of R707. (A) Assays 
with Mn2+, Mg2+, or Ca2+ and in absence of divalent metal ions. (B) Nucleotide sugar 
Manuscript I: Glycogenin-1 paralog in giant mimivirus 
68 
donor specificity using UDP-Glc or UDP-GlcNAc or UDP-Gal or UDP-Xyl. (C) Acceptor 
substrate specificity using pNP-α-Glc, pNP-α-Xyl, pNP-α-Gal, or pNP-α-Rha. Two 
independent experiments with triplicates in each instance were performed. Results are 
shown as mean ± SEM. 
SUPPLEMENTARY FIGURE 2 Heteronuclear single quantum coherence (HSQC) 
signals of peaks A and B 
SUPPLEMENTRAY FIGURE 3. Heteronuclear single quantum coherence (HSQC) 
signals of peak C and pNP-maltose. 
SUPPLEMENTARY FIGURE 4. Product analysis of peaks A, B, and C by negative-ion 
ESI-MS. 60 pmol of products were subjected to analysis. The inserted symbols represent 
the proposed assignments. 
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TABLE I PCR primers used to construct mutated R707. Underlined bases mark the 
introduced mutations. F: forward primer, R: reverse primer. 
Mutated 
Residue 
Primer sequence 
mR707-
Asp103Ser 
F 5’-CGATAAAATTATTTTATTAGATTTAAGCATGATAATTGC-3’ 
R 5’-GCAATTATCATGCTTAAATCTAATAAAATAATTTTATCG-3’ 
mR707-
Tyr215Phe 
F 5’-GGGTTGACACATCGAGTAAAAAAGTTCCATTATACAATTGA-
3’ 
R 5’-CAATTGTATAATGGAACTTTTTTACTCGATGTGTCAACCC-3’ 
mR707-
Lys232Arg 
F 5’-
CATTTTTCTAGTTCCTATCGACCATGGAACAGATTAAATTCCGAC-
3’ 
R 5’-
CGGAATTTAATCTGTTCCATGGTCGATAGGAACTAGAAAAATGA-
3’ 
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ABSTRACT  
The giant Acanthamoeba polyphaga mimivirus encodes 1’262 genes. Several of these genes 
are part of a thought to be virus-specific glycosylation machinery, like enzymes 
involved in the synthesis of nucleotide-diphospho sugars and putative 
glycosyltransferases. Among them we identified L373 as putative glycosyltransferase 
with a predicted mannosyl- and N-acetylglucosaminyltransferase activity. We could 
show specific hydrolysis of UDP-GlcNAc, but not GDP-Man, in a divalent metal ion 
dependent manner. Taking into account that mimivirus expresses a functional pathway 
for the synthesis of UDP-GlcNAc our data gives further evidence for the presence of a 
host-independent UDP-GlcNAc utilization of mimivirus. 
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ABBREVIATIONS 
Fuc fucose 
Gal galactose 
Glc glucose 
GlcNAc N-acetylglucosamine 
HexNAc N-acetylhexosamine 
Man mannose 
pNP 4-nitrophenyl 
Rha rhamnose 
UDP uridine diphosphate 
Vio viosamine 
Xyl xylose 
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INTRODUCTION 
Acanthamoeba polyphaga mimivirus is a giant virus with a 1.2 Mbp genome encoding 
1’262 genes (1). The icosahedral particle with a diameter of 400 nm is covered with 
glycosylated protein fibers (2). Many mimivirus genes code for factors typical for 
cellular life and are novel in viruses (1). 
Among these genes several are involved in the synthesis of nucleotide-diphospho 
sugars, namely UDP-N-acetylglucosamine (GlcNAc), UDP-rhamnose (Rha), and UDP-
viosamine (Vio) (3-5). Three enzymes are involved in the synthesis of UDP-GlcNAc: a 
glutamine-fructose-6-phosphate transaminase, a glucosamine-6-phosphate N-
acetyltransferase, and a UDP-GlcNAc pyrophosphorylase. The viral pathway follows 
both an eukaryotic-like strategy and a prokaryotic-like strategy (3). The nucleotide 
sugars synthesized host-independently reflect the monosaccharide composition of 
mimivirus: GlcNAc, Rha, Vio, together with glucose (Glc), are the major 
monosaccharides in mimivirus. Small amounts of fucose (Fuc) and xylose (Xyl) and 
methylated variations thereof are also found (5, 6). Traces of ribose, mannose (Man), 
arabinose and galactose (Gal) are also detected in mimivirus (5). Although GlcNAc is 
highly abundant in mimivirus in a study analyzing mimivirus O-glycan structures 
GlcNAc is underrepresented. The majority of identified mimivirus O-glycans are linear 
hexose (probably Glc) polymers with varying reducing end residues. Some branched 
structures were also identified consisting of a hexose at the reducing end and a terminal 
HexNAc (probably GlcNAc) residue and a terminal pentose residue linked to HexNAc 
(6). 
Analysis of the mimivirus genome suggests that in addition to the nucleotide-
diphospho sugar synthesizing machinery mimivirus encodes at least 11 putative 
glycosyltransferases that share homologies with eukaryotic, prokaryotic, and archaeal 
glycosyltransferases. The first characterized mimivirus glycosyltransferase is encoded 
Manuscript II: A UDP-GlcNAc hydrolyzing enzyme in mimivirus 
85 
by ORF L230. L230 is a bifunctional enzyme hydroxylating lysine and glucosylating 
hydroxylysine in mimivirus collagen substrates (7). Nothing is known about the 
functionality and role of the other putative mimivirus glycosyltransferases to date. In 
this study we investigated the functionality of mimivirus ORF L373 which is annotated 
as putative glycosyltransferase. 
EXPERIMENTAL PROCEDURES  
Expression and purification of recombinant L373 protein - Recombinant L373 was 
expressed in Spodoptera frugiperda Sf9 cells (Invitrogen, Carlsbad, CA) as FLAG-
fusion protein in pFastBac-FLAG(C) vector (Invitrogen). Viral DNA was purified 
using phenol/ chloroform (Roth, Karlsruhe, Germany). The DNA sequence 
corresponding to mimivirus L373 (RefSeq ID NC_014649.1) was amplified using the 
primers: 5’-GCCGGATCCATTCCTAATATTATTCAT-3’ and 5’-CGCTCTAGATC-
AAGACTTGTTAAAT-3’ containing BamHI and XbaI restriction sites, respectively 
(underlined bases). Recombinant baculoviruses were produced in Sf9 cells as 
described in Hennet et al. (8). 
Control of Protein Expression - For protein separation 5 μl of post nuclear supernatant 
from Sf-9 cells overexpressing L373 were subjected to 14% SDS-PAGE. Proteins were 
transferred to nitrocellulose membrane (GE Healthcare, Glattbrugg, Switzerland) in 
semi-dry manner. After transfer the blot was blocked in 10% bovine serum albumin 
(BSA) (Sigma-Aldrich, Buchs, Switzerland) in PBS-Tween (0.01%) (PBS-T) at room 
temperature for 1 h. Primary anti-FLAG antibody (Sigma-Aldrich) was diluted 
1:5’000 in PBS-T/ 1% BSA and incubated at 4°C overnight. After three 5 min wash 
steps in PBS-T the blot was incubated with secondary peroxidase conjugated goat 
anti-rabbit IgG (Sigma-Aldrich), diluted 1:10’000 in PBS-T/ 1% BSA at room 
temperature for 1 h. After three 5 min wash steps in PBS-T the blot was developed 
with SuperSignal chemiluminescent substrate (Thermo Scientific, Waltham, MA). 
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Enzymatic activity – Glycosyltransferase activity was measured in 20 mM Tris-HCl pH 
7.4 containing 0.5 μl 20 μCi/ml UDP/GDP-[14C]-sugar, 30 μM UDP/GDP-sugar, 10 mM 
MnCl2 (Sigma-Aldrich), 1 mM DTT (Sigma-Aldrich), 20 mM 4-nitrophenyl (pNP)-sugar 
in DMSO (Sigma-Aldrich) or 20 μg mimivirus peptides or 20 μg mimivirus proteins, 
and 10 μg post nuclear supernatant from Sf-9 cells overexpression L373 or from Sf-9 cells 
infected with the empty control vector. The nucleotide-sugars tested as donor substrates 
were UDP-Glc, UDP-GlcNAc, and GDP-Man. The pNP-sugars tested as acceptor 
substrates were pNP-α-Fuc, pNP-α-Gal, pNP-α/β-Glc, pNP-α/β-GlcNAc, pNP-α-Rha, 
pNP-α-Xyl (Sigma-Aldrich). The peptides tested were synthesized from mimivirus 
ORFs L357, L410, R135, and R459. The proteins tested, ORF L425, R459, and R856, were 
expressed in Escherichia coli BL21 De3 (Novagen, Nottingham, UK) as His10-fusion 
proteins and purified by affinity chromatography substantially as described previously 
(7). Assays were incubated at 30°C for 4 h. Assays without acceptor substrate were 
stopped by addition of ice cold 900 μl H2O, and purified over Ag1-X8 resin (Biorad, 
Hercules, CA). Samples were added to the column, flow-through was collected and 
product was eluted with 1 ml H2O. Assays containing pNP-sugar as acceptor were 
stopped by addition of ice cold 500 μl H2O, and purified over SepPak-C18 cartridges 
(Waters, Milford, MA). Samples were added to the cartridges, washed with 10 ml of 
H2O, and eluted with 5 ml of methanol (Sigma-Aldrich). Radioactivity was measured 
after addition of 10 ml of IRGASAFE scintillation liquid (Perkin-Elmer, Waltham, MA) 
in a Tri-Carb 2900TR scintillation counter (Perkin-Elmer). Assays containing mimivirus 
peptides or proteins as acceptor were stopped with 500 μl 5% TCA/ 5% phosphotungstic 
acid and incubated on ice for 30 min. Precipitates were recovered on 1 μm glass filters 
(VWR, Radnor, PA) using a vacuum manifold and radioactivity was measured as 
described above. 
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Statistical analysis - ANOVA with multiple comparisons was used and a P-value of P < 
0.05 was accepted as statistically significant. GraphPad Prism 6 (GraphPad Software, 
Inc., La Jolla, CA) was used for statistical analysis. Results are presented as mean ± SEM. 
RESULTS 
The mimivirus protein was identified as putative glycosyltransferase based on 
sequence similarities to prokaryotic and yeast glycosyltransferases. Based on BLAST 
analysis of the 251 amino acid protein L373 an N-terminal glycosyltransferase 
superfamily domain spanned residues 18 to 97 (Figure 1A). L373 was grouped 
within glycosyltransferase 32 family. Glycosyltransferase 32 family has more than 
1’700 members of which 20 are characterized (9). Of these 20 glycosyltransferases 
the majority are eukaryotic and prokaryotic mannosyltransferases. In L373 an OCH1 
multi-domain was predicted to be spanning residues 1 to 175 (Figure 1A). OCH1 is a 
yeast mannosyltransferase situated in the cis-Golgi apparatus. OCH1 initiates 
synthesis of poly-Man elongation of N-linked oligosaccharides of yeast 
glycoproteins (10). Other characterized members of glycosyltransferase 32 family are 
galactosyl-, N-acetylgalactosaminyl-, and two N-acetylglucosaminyltransferases. In 
L373 a capsular polysaccharide synthesis multi-domain was predicted to be 
spanning residues 5 to 136 (Figure 1A). This domain is found in a bi-specific α-
GlcNAc/α-Glcl-transferase (Uniprot ID: Q4K231) encoded by wcrL which is involved 
in the synthesis of the capsular polysaccharide in Streptococcus pneumonia 70/86 (11, 
12). The DXD motifs of L373 and WcrL align (Figure 1B). The DXD motif is involved 
in the coordination of a divalent metal ion in the catalytic pocket of many 
glycosyltransferases utilizing nucleotide-activated sugars as donor substrates (13).  
The protein L373 was expressed as FLAG-fusion protein in Sf-9 insect cells. L373 
PCR product was cloned into pFastBac-FLAG(C) using BamHI and XbaI (Figure 2A). 
To control protein expression 5 μl post nuclear supernatant were used for an anti-
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FLAG Western blot which showed a single band at 31.6 kDa corresponding to 
FLAG-L373 (Figure 2B). Sequence analysis suggested mannosyl- or N-acetyl-
glucosaminyltransferase activity for L373. While GlcNAc is highly abundant in 
mimivirus only traces of Man are found (6). Post nuclear supernatant from Sf-9 cells 
overexpression L373 or from Sf-9 cells infected with the empty control vector was 
tested for nucleotide-sugar donor hydrolyzing activity. L373 showed a specific 
hydrolysis of UDP-GlcNAc with an average activity of 367.6 pmol/min/μg. L373 did 
not hydrolyze UDP-Glc or GDP-Man at a significant level in comparison to the 
negative control (Figure 3A). Glycosyltransferases with a DXD motifs are often 
dependent on divalent metal ions that are involved in stabilizing the catalytic pocket 
(13). In absence of MnCl2 the UDP-GlcNAc hydrolysis activity of L373 was reduced 
to background levels (Figure 3B). We used a broad variety of acceptor substrates in 
combination with UDP-GlcNAc as nucleotide sugar donor to determine the 
glycosyltransferase activity of L373 (Table 1). We tested mimivirus total protein 
content and some known or predicted glycoproteins or peptides thereof ((14, 15), A. 
Hülsmeier, unpublished data). In addition we tested various pNP-monosaccharides 
that reflected the sugar content of mimivirus (5, 6). There was no glycosyltransferase 
activity detected on the tested proteins, peptides, and pNP-monosaccharides (data 
not shown). 
DISCUSSION  
We have shown that mimivirus L373 is a functional UDP-GlcNAc specific hydrolase 
with glycosyltransferase characteristics. L373 had homologies to both N-
acetylglucosaminyl- and mannosyltransferases. The majority of glycosyltransferases, 
however, are donor-specific and do not use multiple nucleotide-sugar donors (16). This 
holds true for L373 as L373 did not hydrolyze GDP-Man. This finding goes in hand with 
the monosaccharide composition of mimivirus where GlcNAc is a major component 
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while only traces Man are found (5, 6). Sequence analysis of L373 identified a DXD motif 
within the predicted glycosyltransferase domain suggesting a dependence on divalent 
metal ions (13). Indeed, in absence of Mn2+ L373 hydrolysis activity was shed. We were 
able to rule out a variety of acceptor substrates of L373. Although a number of possible 
acceptors are known a broader screening of possible acceptor proteins and more 
complex carbohydrate acceptors would be necessary for L373 glycosyltransferase 
activity determination. Only a limited number of glycosylated proteins and peptides are 
known in mimivirus ((14, 15), A. Hülsmeier, unpublished data). It is likely that the 
sequon recognized by mimivirus glycosyltransferases differs from the canonical sequon. 
In Paramecium bursaria chlorella virus, another giant virus with host-independent 
glycosylation, the identified N-glycosylation sequon is unusual and differs from the 
eukaryotic sequon (17). It is therefore hard to predict possible mimivirus glycoproteins 
and glycosylation sites for core N-glycosyltransferases. From an O-glycan analysis in 
mimivirus we know that GlcNAc is mainly found in the terminal position of branched 
O-glycans (6). There is a limitation in availability of such complex glycans as suiting 
acceptor substrate for elongating glycosyltransferases. Most available pNP- or benzyl-
coupled saccharides, which allow product purification, are monosaccharides or linear 
structures, but not complex, branched structures. L373 might, however, only be active as 
elongating enzyme if the core glycan is mature enough. It is common for 
glycosyltransferases to show strict acceptor specificity (18). As there is nothing known 
on mimivirus N-glycans and the location of the majority of mimiviral GlcNAc it is 
impossible to make further predictions on the glycosyltransferase activity of L373 to 
date. 
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FIGURE LEGENDS 
FIGURE 1. (A) BLAST analysis of the 251 amino acid protein L373 with predicted 
domains. The glycosyltransferase (GT) sugar binding region was predicted to be 
spanning residues 18 to 97, the OCH1 domain was predicted to be spanning residues 1 
to 175, and the capsular polysaccharide synthesis protein domain was predicted to be 
spanning residues 5 to 136. (B) Multiple sequence alignment of OCH1, L373, and WcrL. 
Identical residues are shaded in black. Similar residues are shaded in gray. DXD motif is 
marked by dashed box.  
FIGURE 2. (A) Vector map of pFastBac-FLAG(C)-L373. XbaI and BamHI were used for 
cloning of L373 PCR product. The plasmid contained a gentamycin resistance (GmR), an 
ampicillin resistance (AmpR) and the bacterial transposons Tn7R/ Tn7L. (B) Anti-FLAG 
Western blot of Sf-9 post nuclear cell lysate from Sf-9 cells overexpressing L373. The 
band at 31.6 kDa corresponds to FLAG-L373. 
FIGURE 3. (A) Hydrolysis activity of L373 using UDP-Glc, UDP-GlcNAc, and GDP-
Man in vitro. Grey bars represent Sf-9 cells infected with empty control vector 
(pFB_empty). Open bars represent Sf-9 cells overexpressing L373 (pFB_L373). (B) UDP-
GlcNAc hydrolysis activity of L373 in presence and absence of Mn2+. Two independent 
experiments with triplicates in each condition were done. Results are shown as mean ± 
SEM. 
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TABLE 1. Acceptor substrates used to identify glycosyltransferase activity of L373. 
Type of acceptor 
substrate 
Mimivirus ORF number or chemical name 
Full length proteins  L425, R459, R856 
Peptides L357, L410, R135, R459 
pNP-monosaccharides pNPαFuc, pNPαGal, pNPα/βGlc, pNPα/βGlcNAc, pNPαRha, 
pNPαXyl 
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ADDITIONAL RESULTS 
CLONING, EXPRESSION, AND ACTIVITY SCREENING OF PUTATIVE MIMIVIRUS 
GLYCOSYLTRANSFERASES 
EXPERIMENTAL PROCEDURES 
Expression and purification of recombinant glycosyltransferase candidates 
Recombinant L193, R139, R363, and R654 were expressed in E. coli BL21 Rosetta as His10-
fusion protein in pET16b or pET28a (Merck, Darmstadt, Germany). Viral DNA was 
purified using phenol/ chloroform (Roth, Karlsruhe, Germany). The DNA sequences 
corresponding to mimivirus L193, R139, R363, and R654 (GenBank Accession number: 
NC_014649.1) were amplified using the primers listed in table 5. The amplification 
primers incorporated a restriction endonuclease site (New England Bioscience, Hitchin, 
UK) (Table 5). For protein expression 100 ml lysogeny broth containing 100 μg/ml 
ampicillin or 50 μg/ml kanamycin (both from Sigma-Aldrich, Buchs, Switzerland) were 
inoculated with 1 ml from an overnight culture. Protein expression was induced with 1 
mM isopropyl-β-D-thiogalactopyranoside (Biosolve, Dieuze, France) at OD600 of 0.4-0.6. 
After induction E. coli were grown shaking as follows: L193 at 16°C for 22 h, R139 at 
30°C for 1.5 h, R363 at 16°C for 6 h, and R654 at 30°C for 1.5 h, then pelleted at 6’000 x g, 
resuspended in 15 ml 500 mM NaCl, 20 mM Tris pH 7.4, 10% v/v glycine, 10 mM 
imidazole (MCAC10) and lysed by an Emulsiflex C5 French press (Avestin, Mannheim, 
Germany). His-tagged proteins were purified from the soluble fraction using 100 μl Ni-
Sepharose 6 Fast Flow beads (GE Healthcare, Glattbrugg, Switzerland). After binding to 
beads in MCAC10 at 4°C for 4 h, rotating, proteins were eluted with 400 mM imidazole 
(MCAC400). 
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Table 5 Primers, vectors, and restriction enzymes used for cloning of putative mimivirus 
glycosyltransferases 
ORF Forward primer (5’-3’) Reverse primer (5’-3’) PCR 
product 
(bp) 
Vector (restriction 
enzymes) 
R139 ATAGAATTCATGTCC
AATCAAGCAACATCT
G 
AATACTCGAGATTC
TTTATGGAACCCTC
CTCA 
763 pET28 (EcoRI, 
XhoI) 
L193 CGCAAGCTTGATTCC
TGTTACAATCCTCAC 
CGCCTCGAGTGGAG
TTTCAAACAGATTA
ATC 
1’841 pET28 (HindIII, 
XhoI) 
R363 ATACAAGCTTATGCA
AGAAATAAATGGCA
CATCTC 
AATCTCGAGTTCAA
TACATTCCACGTAC
TCTTG 
787 pET28 (HindIII, 
XhoI) 
R654 ATACTCGAGGAAAG
CTGTAAAATTATTTG
TA 
ATAGGATCCTTAAA
TGTATAATGTTTGA
ATT 
1’871 pET16 (XhoI, 
BamHI) 
 
Control of Protein Expression 
For protein separation 15 μl of purified enzyme were subjected to 10% SDS-PAGE. 
Proteins were transferred to nitrocellulose membrane (GE Healthcare) in semi-dry 
manner. After transfer the membrane was blocked in 5% milk in PBS-Tween (0.01%) 
(PBS-T) at room temperature for 1 h. Primary anti-His antibody (Sigma-Aldrich) was 
diluted 1:5’000 in PBS-T containing 1% bovine serum albumin (BSA) (Sigma-Aldrich) 
and either incubated at room temperature for 1 h or at 4°C overnight. After antibody 
incubation the membrane was washed three times for 5 min in PBS-T followed by 
incubation with secondary antibody, peroxidase conjugated goat anti-mouse IgG 
(Sigma-Aldrich, Buchs, Switzerland) diluted 1:10’000 in PBS-T/ 1% BSA at room 
temperature for 1 h. After antibody incubation the membrane was washed three times 
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for 5 min in PBS-T followed by development with SuperSignal chemiluminescent 
substrate (Thermo Scientific, Waltham, MA). 
Determination of activity 
Glycosyltransferase activity was measured in 20 mM Tris-HCl pH 7.4 containing 0.5 μl 
20 μCi/ml UDP-[14C]-Glc or UDP-[14C]-GlcNAc or GDP-[3H]-Fuc (Perkin-Elmer, 
Waltham, MA or American Radio Chemicals, St. Louis, MO), 20-50 μM UDP-sugar 
(Sigma-Aldrich or Carbosynth, Compton, UK), 10 mM MnCl2 (Sigma-Aldrich), 1 mM 
DTT (Sigma-Aldrich), 10-50 mM 4-nitrophenyl (pNP)-sugar in DMSO (Sigma-Aldrich) 
as acceptor substrate or 20 μg mimivirus peptides (GenScript, Piscataway Township, 
NJ), and 10 μg of purified protein. The UDP-sugars tested as donor substrates were 
UDP-Glc, UDP-GlcNAc, GDP-Fuc, UDP-Rha, and UDP-Vio. The pNP-sugars tested as 
acceptor substrates were pNP-α/β-Glc, pNP-α/β-GlcNAc, and pNP-α-Rha (Sigma-
Aldrich). Assays were incubated at 35°C for 4 h. Assay containing pNP-sugars were 
stopped by addition of ice cold 500 μl H2O, and purified over SepPak-C18 cartridges 
(Waters, Milford, MA). Samples were added to the cartridges, washed with 10 ml of 
H2O, and eluted with 5 ml of methanol (Sigma-Aldrich). Radioactivity was measured 
after addition of 10 ml of IRGASAFE scintillation liquid (Perkin-Elmer) in a Tri-Carb 
2900TR scintillation counter (Perkin-Elmer). Assays containing mimivirus peptides were 
stopped by addition of 500 μl 5% TCA / 5% phosphotungstic acid and incubated on ice 
for 30 min. Precipitates were recovered on 1 μm glass filters (VWR, Radnor, PA) using a 
vacuum manifold and radioactivity was measured as described above. Assays 
containing UDP-Vio or UDP-Rha (kindly provided by M. Tonetti) were incubated under 
the same conditions without the supplementation of radioactively labeled nucleotide 
sugar donor. The release of UDP was measured using the UDP-Glo kit (Promega, 
Madison, WI) following the manufacturer’s manual. 
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RESULTS 
Mimivirus L193 is a 601 amino acid protein with a molecular weight of 70.8 kDa. BLAST 
analysis predicted the presence of two glycosyltransferase domains: an N-terminal GT-
A domain and a C-terminal GT-B domain (Figure 12). The GT-A domain of L193 
showed sequence homologies to GT 2 family proteins. GT 2 has almost 70’000 family 
members of which 269 are characterized (1, 2). These glycosyltransferases are all 
inverting enzymes, but show a huge variety in terms of functionality and are found 
amongst archaea, bacteria, and eukaryotes. In L193 a WcaA multi-domain was predicted 
to be spanning residues 1 to 280 including the GT-A domain. WcaA is involved in the 
synthesis of colanic acid in E. coli. Colanic acid is a polyanionic heteropolysaccharide 
containing a repeat unit with D-Glc, L-Fuc, D-Gal, and D-glucuronate sugars that are 
nonstoichiometrically decorated with O-acetyl and pyruvate side chains (3). The GT-B 
domain showed sequence homologies to GT 1 family proteins. GT 1 contains more than 
9’700 members of which 366 are characterized (1, 2). These glycosyltransferases show a 
huge variety in terms of functionality and are found amongst bacteria and eukaryotes. 
An RfaG multi-domain was predicted to be spanning the GT-B domain. RfaG is 
involved in the core synthesis of E. coli LPS (4). Phyre2 predicted a GT 1 family domain 
in the C-terminus of L193 with a UDP-glycosyltransferase/glycogen phosphorylase fold 
and homologies to starch synthase. 
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Figure 12 BLAST analysis of mimivirus ORFs L193, R139, R363, and R654with predicted 
domains. L193 was predicted to have an N-terminal glycosyltransferase (GT)-A type domain 
and a C-terminal GT-B type domain. R139 and R363 were predicted to have an N-terminal GT-A 
type domain. R654 was predicted to have a C-terminal GT-10 domain. 
Mimivirus R139 is a 248 amino acid protein with a molecular weight of 28.9 kDa. BLAST 
analysis predicted an N-terminal GT-A domain (Figure 12). R139 showed sequence 
homologies to prokaryotic glycosyltransferases. BLAST search, however, resulted only 
in uncharacterized GT 2 family proteins or hypothetical proteins. Mimivirus R139 was 
found in the same locus as two nucleotide-diphospho sugar synthetizing enzymes of 
mimivirus, namely L136, an enzyme involved in the synthesis of UDP-Vio, and L141, an 
enzyme involved in the synthesis of UDP-Rha (5, 6). Phyre2 analysis of R139 predicted a 
nucleotide-diphospho sugar transferase fold, possibly being a polypeptide N-acetyl-
galactosaminyltransferase, a chondroitin polymerase, or a mannosyl-3-phospho-
glycerate synthase. 
Mimivirus R363 is a 256 aa protein with a molecular weight of 29.4 kDa. BLAST analysis 
predicted an N-terminal GT-A domain (Figure 12). R363 showed sequence homologies 
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with giant virus, cyanobacterial, and archaeal glycosyltransferases. BLAST search, 
however, resulted only in uncharacterized glycosyltransferases or hypothetical proteins. 
R363 was grouped within GT 2 family. Phyre2 analysis predicted R363 to be a 
chondroitin synthase with an N-acetyl-galactosaminyltransferase activity. 
Mimivirus R654 is a 600 aa protein with a molecular weight of 70.7 kDa. BLAST analysis 
predicted C-terminal GT 10 superfamily domain (Figure 12). R654 showed sequence 
homologies with both prokaryotic and eukaryotic fucosyltransferases throughout the 
glycosyltransferase domain. R654 was grouped within GT 10 family. 
Glycosyltransferase 10 has more than 500 members of which 45 are characterized (1, 2). 
All members of GT 10 contain a GT-B fold, work in an inverting way, and have catalytic 
activity as prokaryotic or eukaryotic fucosyltransferases forming either α1,3- or α1,4-
linkages. Phyre2 analysis predicted domain and secondary structure homologies to 
fucosyltransferase -like glycosyltransferases. 
L193, R139, and R363 were expressed in E. coli BL21 Rosetta as C-terminal His10-fusion 
proteins; R645 was expressed in E. coli BL21 Rosetta as N-terminal His10-fusion protein. 
To control protein expression and purification 15 μl proteins in MCAC400 were 
subjected to SDS-page followed by an anti-His Western blot. All glycosyltransferase 
candidates were detected at the expected protein size (Figure 13). 
 
Figure 13 Anti-His Western blot of recombinantly expressed and purified L193 (70.8 kDa), 
R139 (28.9 kDa), R363 (29.4 kDa), and R654 (70.7 kDa). Single bands correspond to the 
predicted protein sizes. 
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Sequence analysis of L193 did not give clear hints towards the functionality of L193. 
Therefore we did a broad screening with the main monosaccharides found in mimivirus 
as nucleotide sugar donor and a variety of both peptide and monosaccharide acceptors 
(5-8). We did not detect any L193 glycosyltransferase activity within the conditions 
tested (Table 6). 
Table 6 Tested combinations of donor nucleotide sugars and acceptor substrates and L193 as 
putative glycosyltransferase in vitro X indicates the absence of glycosyltransferase activity. 
 Donor nucleotide sugar 
Acceptor substrate UDP-Glc UDP-GlcNAc UDP-Vio UDP-Rha 
L357 X X X X 
L410 X X X X 
R135 X X X X 
R459 X X X X 
pNP-Glc (α or β) or 
Glc 
X X X X 
pNP-GlcNAc (α or 
β) or GlcNAc 
X X X X 
pNPαRha or Rha X X X X 
 
Sequence analysis of R139 did not give any clear hints towards the functionality of R139. 
As member of the same gene cluster like two enzymes involved in the synthesis of UDP-
Rha (R141) and UDP-Vio (L136), we focused on using UDP-Vio and UDP-Rha as donor 
nucleotide sugars in a first round of activity tests (5, 6). Since we did not detect any 
glycosyltransferase activity using UDP-Rha and UDP-Vio, we tested UDP-Glc and UDP-
GlcNAc as nucleotide sugar donors. We did not detect any R139 glycosyltransferase 
activity within the conditions tested (Table 7). 
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Table 7 Tested combinations of donor nucleotide sugars and acceptor substrates and R139 as 
putative glycosyltransferase in vitro. X indicates the absence of glycosyltransferase activity. 
 Donor nucleotide sugar 
Acceptor substrate UDP-Glc UDP-GlcNAc UDP-Vio UDP-Rha 
L357 X X X X 
L410 X X X X 
R135 X X X X 
R459 X X X X 
pNPαGlc X X X X 
pNPβGlc X X X X 
pNPαGlcNAc X X X X 
pNPαRha X X X X 
 
Sequence analysis of R363 did not give any clear hints towards the functionality of R363. 
Therefore we did a broad screening with the main monosaccharides found in mimivirus 
as donor nucleotide sugar and a variety of both peptide and monosaccharide acceptors. 
We did not detect any R363 glycosyltransferase activity within the conditions tested 
(Table 8). 
Table 8 Tested combinations of donor nucleotide sugars and acceptor substrates and R363 as 
putative glycosyltransferase in vitro. X indicates the absence of glycosyltransferase activity. 
 Donor nucleotide sugar 
Acceptor substrate UDP-Glc UDP-GlcNAc UDP-Vio UDP-Rha 
L357 X X X X 
L410 X X X X 
R135 X X X X 
R459 X X X X 
pNP-Glc (α or β) or X X X X 
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Glc 
pNP-GlcNAc (α or 
β) or GlcNAc 
X X X X 
pNPαRha or Rha X X X X 
 
Sequence analysis suggested fucosyltransferase activity for R654. Therefore, we used 
GDP-Fuc and various acceptors to test for R654 activity. As we did not identify any 
specific activity we continued with a broad screen with the main monosaccharides 
found in mimivirus as donor nucleotide sugar and a variety of both peptide and 
monosaccharide acceptors We could not detect any R654 glycosyltransferase activity in 
the conditions tested (Table 9). 
Table 9 Tested combinations of donor nucleotide sugars and acceptor substrates and R654 as 
putative glycosyltransferase in vitro. X indicates the absence of glycosyltransferase activity. 
 Donor nucleotide sugar  
Acceptor substrate GDP-Fuc UDP-Glc UDP-
GlcNAc 
UDP-Vio UDP-Rha 
L357 X X X X X 
L410 X X X X X 
R135 X X X X X 
R459 X X X X X 
pNP-Glc (α or β) or 
Glc 
X X X X X 
pNP-GlcNAc (α or 
β) or GlcNAc 
X X X X X 
pNPαRha or Rha X X X X X 
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DISCUSSION 
We recombinantly expressed and purified the four putative mimivirus glycosyl-
transferases L193, R139, R363, and R654. We could rule out a number of possible 
glycosyltransferase activities for all candidates. The viral proteins were recombinantly 
expressed in E. coli BL21 Rosetta but not in any other E. coli strain. The BL21 Rosetta 
strain is designed to enhance expression of eukaryotic proteins. They supply codons 
rarely used by E. coli thus providing for universal translation (9-12). It is likely that the 
codons naturally provided by E. coli are not sufficient for translation of mimivirus 
proteins because many of the mimivirus proteins have eukaryotic origin or a common 
evolutionary background with eukaryotic proteins (13). 
L193, R139, R363, and R654 were not active under the tested conditions in vitro. This 
could be due to various reasons. Many glycosyltransferases have both N- and O-
glycosylation sites themselves (14). The consensus glycosylation sequences of eukaryotic 
and prokaryotic glycosylation sites are not necessarily the same as in giant viruses. Due 
to recombinant expression in E. coli, the mimivirus glycosyltransferases would lack this 
glycosylation necessary for their activity. 
Most glycosyltransferases work in a strict acceptor specific manner. For example, the 
human B blood group α1,3 galactosyltransferase is only active if the Gal residue on the 
acceptor substrate is linked to Fuc in an α1,2 linkage and not if the Gal residue is 
modified by other monosaccharides (15). The commercial availability of complex 
glycans as possible acceptors substrates is limited, even with a number of O-glycan 
structures known (8). 
In mimivirus, various glycans are further modified by methylation. Methylation is 
described for GlcNAc, Rha, and Vio (8). Methylation is mostly performed as the final 
modification step after biosynthesis of the glycan. Mycobacteria, however, express a 
rhamnosyltransferase that transfers methylated Rha to the oligosaccharide acceptor 
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chain (16). If mimivirus glycosyltransferases have a preference towards the methylated 
donor nucleotide sugar detection of glycosyltransferase activity in vitro using non-
methylated donor nucleotide sugar is impossible. 
Little is known about the composition of the virus factory and we do not know whether 
the presence of certain co-factors or complex partners is necessary for proper 
functioning of mimivirus glycosyltransferases. Cellulose biosynthesis in bacteria for 
example is catalyzed by a protein complex consisting of a glycosyltransferase (BcsA), a 
membrane-associated periplasmic protein (BcsB), and an outer membrane protein 
(BcsC) (17). 
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GENOME ENGINEERING IN MIMIVIRUS USING THE CRISPR-CAS9 SYSTEM IN 
ACANTHAMOEBA 
EXPERIMENTAL PROCEDURES AND RESULTS 
To develop a tool for the knock-out of single or multiple mimivirus genes we adapted 
the clustered regularly interspaced short palindromic repeats (CRISPR) adaptive 
immune system from microbes which used for genome engineering in a broad range of 
species (1-3). In order to produce knock-outs of mimivirus genes we manipulated a 
CRISPR plasmid for Acanthamoeba specific expression of Cas9 and gRNA. Transfection 
with the Acanthamoeba specific CRISPR plasmid would allow us to target any mimivirus 
gene by cloning of a mimivirus specific gRNA into the plasmid. We used the pSpCas9 
(BB)-2A-Puro (PX459) plasmid (Addgene plasmid # 62988, gifted from Feng Zhang) 
which was designed for expression in mammalian cells and has a FLAG-tagged Cas9 
from Streptococcus pyogenes with a C-terminal puromycin resistance and a cloning site 
for gRNA (Figure 14A) (3). We modified this in plasmid in three steps to generate a 
plasmid for transfection, Cas9 and gRNA expression in Acanthamoeba (Figure 14). 
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Figure 14 A Vector map of pSpCas9 (BB)-2A-Puro (PX459). The exchanged cassettes 
(mammalian promoter cassettes and ampicillin cassette) are shaded in light gray. The plasmid 
contains an ampicillin resistance cassette (AmpR) with the necessary ampicillin promoter 
(Amp_P). PciI, XbaI, AgeI, AclI mark restriction enzyme sites that were used for cassette 
exchange. B. Newly introduced cassettes tailored for gRNA, Cas9 expression, and selection in 
Acanthamoeba. Acanthamoeba castellanii U6 spliceosomal RNA promoter (AC_U6 promoter) and 
Acanthamoeba castellanii polyubiquitin promoter (AC_polyubiquitin promoter) were cloned into 
PX459 to drive amoeba specific gRNA and Cas9 expression. BbsI restriction enzyme sites were 
used for introduction of gRNA. For selection in bacteria and amoeba a kanamycin/neomycin 
resistance cassette (KanR/NeoR) containing the bacterial (Kan_P) and amoebal promoter 
(SV40_P) was introduced. 
In a first step we exchanged the human U6 promoter driving gRNA expression with the 
corresponding sequence from Acanthamoeba. In 2008 a U6 spliceosomal RNA sequence 
was identified in Acanthamoeba castellanii (4). Using this sequence we analyzed the 
Acanthamoeba genome to target the upstream promoter region (Figure 15A) (5). We had 
the predicted promoter plus the gRNA insertion site, the gRNA scaffold and the U6 
terminator synthesized to facilitate cloning (GenScript, Piscataway Township, NJ) 
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(Figure 14B). The whole cassette was introduced into the PX459 plasmid using PciI and 
XbaI (New England Bioscience, Hitchin, UK). 
 
Figure 15 Acanthamoeba castellanii promoters used for development of an Acanthamoeba 
specific CRISPR plasmid. A. U6 spliceosomal RNA promoter. Underlined bases mark the U6 
spliceosomal RNA. B. Poly-ubiquitin promoter sequence used for driving expression of Cas-9. 
In a second step we exchanged the CBh promoter driving Cas9 expression as the CBh 
promoter is designed for mammalian cell lines (3). We used the polyubiquitin promoter 
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from Acanthamoeba since this promoter was driving protein expression in Acanthamoeba 
in our hands before (S. Deuber, unpublished data) (Figure 15B). The promoter was 
amplified from Acanthamoeba total DNA using the following primers: 5’-
CACTCTAGACCGAGCTCTAGCACAAACTC-3’ and 5’-CACACCGGTGCATGGTT-
GGCTGCTGTGTAG-3’ containing an XbaI and AgeI restriction site (underlined bases), 
respectively. The promoter was introduced into PX459 plasmid using XbaI and AgeI 
(New England Bioscience). Acanthamoeba were not sensitive to puromycin  up to 1 
mg/ml (Sigma-Aldrich, Buchs, Switzerland) but showed dose-dependent killing in 
presence of neomycin (G418) (Life Technologies, Carlsbad, CA) (data not shown). In a 
third step we introduced a cassette for selection of positive Acanthamoeba after plasmid 
transfection. We introduced a kanamycin/ G418 cassette with all necessary promoters 
and terminators into PX459 using AclI (New England Bioscience) (Figure 14B). After 
introduction of the Acanthamoeba specific promoters and the G418 cassette for selection 
the plasmid will be used for transfection into Acanthamoeba to control Cas9 expression 
by an anti-FLAG Western blot (Figure 16). 
 
Figure 16 Vector map of an Acanthamoeba specific CRISPR plasmid. Acanthamoeba castellanii 
U6 promoter (AC_U6_P), Acanthamoeba castellanii polyubiquitin promoter (AC_pUb_P), and the 
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kanamycin/neomycin resistance cassette (KanR/NeoR) containing all necessary promoters 
(KanP, SV40P) were introduced into the vector for amoeba specific expression of gRNA, Cas9, 
and for selection of positive amoeba using neomycin. 
Acanthamoeba will be transfected substantially as described in previously (6). Briefly, 
5*104 will be seeded in 20 mM Tris pH 8.8, 100 mM KCl, 8 mM MgSO4, 0.4 mM CaCl2, 1 
mM NaHCO3 (encystment medium) in 24-wells. In 25 μl encystment medium 1 μg 
plasmid DNA and 5 μl Lipofectamine2’000 (Life Technologies) will be incubated for 10 
min. The mixture will be added to Acanthamoeba and incubated for at 30°C 3 h. The 
transfection mix will then be replaced with growth medium for 24h after which selection 
will be induced with 50 μg/ml G418. Acanthamoeba total cell lysate will be analyzed after 
expansion for Cas9 expression by anti-FLAG Western blot. As proof-of concept we will 
knock-out one Acanthamoeba gene and one mimivirus gene. In Acanthamoeba we chose to 
knock out actin. Actin fibers are mainly found in lamellipodia and acanthopodia (7). 
Knock-out of actin leading to a morphologic change in Acanthamoeba will be detected by 
transmission electron microscopy. In mimivirus we chose to knock out L725, a 
mimivirus fiber protein. Knock-out of L725 leads to a morphologic change in the surface 
fibers and can be controlled by electron microscopy (8). All gRNAs will be cloned into 
the plasmid as described in previously (3). 
  
Additional results 
116 
REFERENCES 
1. Lander ES. The Heroes of CRISPR. Cell. 2016;164(1-2):18-28. Epub 2016/01/16. 
2. Wright AV, Nunez JK, Doudna JA. Biology and Applications of CRISPR Systems: 
Harnessing Nature's Toolbox for Genome Engineering. Cell. 2016;164(1-2):29-44. Epub 
2016/01/16. 
3. Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F. Genome engineering using 
the CRISPR-Cas9 system. Nature protocols. 2013;8(11):2281-308. Epub 2013/10/26. 
4. Davila Lopez M, Rosenblad MA, Samuelsson T. Computational screen for spliceosomal 
RNA genes aids in defining the phylogenetic distribution of major and minor spliceosomal 
components. Nucleic acids research. 2008;36(9):3001-10. Epub 2008/04/09. 
5. Clarke M, Lohan AJ, Liu B, Lagkouvardos I, Roy S, Zafar N, et al. Genome of 
Acanthamoeba castellanii highlights extensive lateral gene transfer and early evolution of 
tyrosine kinase signaling. Genome biology. 2013;14(2):R11. Epub 2013/02/05. 
6. Peng Z, Omaruddin R, Bateman E. Stable transfection of Acanthamoeba castellanii. 
Biochimica et biophysica acta. 2005;1743(1-2):93-100. Epub 2005/03/22. 
7. Gonzalez-Robles A, Castanon G, Hernandez-Ramirez VI, Salazar-Villatoro L, Gonzalez-
Lazaro M, Omana-Molina M, et al. Acanthamoeba castellanii: identification and distribution of 
actin cytoskeleton. Experimental parasitology. 2008;119(3):411-7. Epub 2008/05/20. 
8. Sobhy H, Scola BL, Pagnier I, Raoult D, Colson P. Identification of giant Mimivirus 
protein functions using RNA interference. Frontiers in microbiology. 2015;6:345. Epub 
2015/05/15.  
General discussion 
117 
GENERAL DISCUSSION 
When mimivirus was first described as virus in 2003 the discovery challenged the 
classical dogmas of virology. Viruses were always thought to be small, filterable agents 
(1). This virus, however, was bigger in particle and genome size than various bacteria or 
archaea, parasitic or free-living. Within the past decade more and more giant viruses 
from manifold sources infecting various hosts were discovered (2-6). The size and 
complexity of giant virus genomes raises questions about their host dependence and 
challenges the separation of viruses in comparison to parasitic cellular organisms. Also, 
many of the giant virus genes are novel and unexpected for viruses (7). Most protein 
coding sequences of mimivirus are expressed upon infection of Acanthamoeba 
indicating a role for these genes in the viral life cycle (8). It seems to be vital for 
mimivirus to invest energy in the maintenance of its own biosynthetic pathways, among 
them the glycosylation machinery. The complexity of the mimivirus glycosylation 
machinery suggests an important role of virus-specific, host-independent glycosylation 
in the infection of amoeba and the replication of mimivirus. We set out to analyze 
putative mimivirus glycosyltransferases in order to help understanding of giant virus 
glycosylation and parallels of giant virus glycosylation to glycosylation in other 
organisms. 
Similarities and differences between mimivirus glycosyltransferases and their 
eukaryotic or prokaryotic homologs could give valuable insight into the functionality of 
glycosyltransferases regarding substrate specificity, linkage formation, and pattern 
recognition on the acceptor substrates. In this work we showed that mimivirus R707 
elongated Glc with Glc in both α1,6 and β1,6 and α1,4 configuration while the 
eukaryotic homolog GYG1 exclusively produces α1,4 linkages between Glc residues (9). 
GYG1 was crystallized in 2002 and the residues involved in nucleotide sugar donor 
coordination in the catalytic pocket are known (9). Crystallization of R707 and 
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comparison of the 3D structure of both proteins might elucidate the mechanism of 
linkage formation in glycosyltransferases. Mimivirus L230 for example adds Glc 
residues to polypeptide Hyl while the human homolog GLT25 transfers Gal residues on 
collagen substrates (10, 11). The exact residues involved in determination of donor 
specificity of glycosyltransferases are not known to date. Structural analysis of 
mimivirus glycosyltransferases, their catalytic pocket and steric changes upon donor 
and acceptor substrate binding together with a thorough sequence analysis could 
answer questions regarding the mechanism of glycosyltransferase catalysis in general. 
LIMITATIONS IN GLYCOSYLTRANSFERASE ANALYSIS 
Considering that 1-2% of all genes are encoding glycosyltransferases studies of glycans 
lag behind those of other major classes of molecules, like DNA or proteins (12). Glycans 
are highly complex, their structure can neither predicted from a template nor does 
universal code for glycans exist. A certain glycosylation site on a protein may be 
glycosylated or not, and different copies of one protein may vary in glycan structure on 
one specific glycosylation site (13). This hampers the study of glycans. In addition, 
possibilities to analyze the complexity of glycans were restricted by a shortage of 
efficient methods. With the development of advanced technologies with powerful 
computational tools the study of glycans has become more feasible (14). Limitations in 
analysis of glycosyltransferases are anyhow still prevailing to date. While the history of 
protein databases reaches back to the 1970s the CAZY database went online in 1998 (15-
19). On CAZY, glycosyltransferases sharing at least 100 amino acids in two different 
stretches with members of one glycosyltransferase family but not to other families this 
glycosyltransferase are assigned to that specific family with the same predicted 
glycosyltransferase fold (20). More than 95% of the annotated glycosyltransferases, 
however, are uncharacterized (12). The putative mimivirus glycosyltransferases, for 
example, were grouped within family 1 (3.5% characterized), family 2 (0.5% 
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characterized), family 8 (1.0% characterized), family 10 (7.5% characterized), and family 
32 (1.0% characterized). Within some families the range of glycosyltransferase activity is 
narrow, while members of another family have a broad range of activities using 
different nucleotide sugar donors, acceptor substrate, form different linkages, and 
originate from different organisms. Glycosyltransferase family prediction can only give 
hints towards the functionality of a certain enzyme. Sequence analysis by BLAST can 
predict certain domains and functionalities. These results, however, are not always 
revealing. The same holds true for protein analysis with tools taking 3D folds into 
account, like Phyre2. In case of the analyzed putative mimivirus glycosyltransferases 
family and domain prediction was helpful in 2 out of 6 cases. Mimivirus R707 was 
predicted to be a GYG1 homolog and indeed R707 was active as elongating 
glucosyltransferase. Linkage formation, however, was different in R707 catalysis. 
Mimivirus L373 showed strongest homologies to fungal mannosyltransferases and an 
N-acetylglucosaminyltransferase from S. pneumonia. L373 hydrolyzed UDP-GlcNAc, 
but not GDP-Man. Mimivirus R654 was predicted to be a fucosyltransferase. Fuc is only 
present in traces in mimivirus. We could not detect any GDP-Fuc hydrolysis or 
fucosyltransferase activity. All other investigated putative mimivirus 
glycosyltransferases were grouped with uncharacterized proteins and families with 
various activities. For those candidates, the bioinformatics tools available to date failed 
to help unraveling the functionality of the glycosyltransferases. 
Another challenge in determination of mimiviral glycosyltransferase activity is the exact 
acceptor substrate specificity of most glycosyltransferases like it is seen for example in 
the human blood group glycosyltransferases (21). To identify a mimivirus core 
glycosyltransferase a library of all mimivirus glycoproteins would be needed. To date 
such a list does not exist and in addition it would be cumbersome to clone and 
recombinantly express all these acceptor proteins. We tried various mimivirus peptides 
with known glycosylation sites as acceptor substrates. As glycosylation in mimivirus 
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might occur on fully folded proteins a peptide alone might not be recognized by the 
viral glycosyltransferase. Even with a number of glycan structures known it is hard to 
get hands on these complex glycan structures as acceptor substrates for elongating 
glycosyltransferases. With nothing known to date about mimivirus N-glycans the hunt 
for glycosyltransferase activity is even more complicated. 
In addition, many glycosyltransferases have both N- and O-glycosylation sites 
themselves (22). The consensus glycosylation sequences and glycan structures of 
eukaryotic and prokaryotic glycosylation differ from those in giant viruses (23, 24). 
Recombinant expression of putative mimivirus glycosyltransferases in a eukaryotic or 
prokaryotic system might hinder proper glycosylation of mimivirus glycosyltransferases 
which might be needed for their activity. 
IN VIVO STUDIES OF MIMIVIRUS GLYCOSYLTRANSFERASES 
Given the fact that mimivirus is one of very few viruses encoding an own glycosylation 
machinery it would be interesting to study the role of mimivirus glycosyltransferases in 
vivo to determine the role of mimivirus glycosylation in infection and replication. 
Depletion of one or a systematic depletion of multiple putative glycosyltransferases 
would allow in depth studying of the role of mimivirus glycosylation in viral infection 
and replication. One could study the changes in surface glycosylation and infection and 
replication rate. A study using RNA interference in mimivirus was published in 2015 
(25). RNA interference, however, is only transient and does not allow virus expansion 
and propagation in large quantities. Genetic engineering of large DNA viruses, like 
herpesviruses and poxviruses, was done in the past using cosmids and bacterial 
artificial chromosomes (26). These techniques, however, are laborious and time-
consuming, and the mimivirus genome is almost 5-10 folds bigger than the genome of 
herpesviruses. The RNA-guided Cas9 nuclease from microbial CRISPR adaptive 
immune system is used for genome engineering in a broad range of species (27-29). The 
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CRISPR-Cas9 is successfully used for herpesvirus generating specific mutated viruses 
within two weeks (30, 31). Adaptation of a CRISPR plasmid for Cas9 and gRNA 
expression in Acanthamoeba would allow us to targeting any mimivirus gene for knock-
out by cloning of a mimivirus specific gRNA into the plasmid. Functionality of the 
plasmid we generated for Acanthamoeba specific expression of Cas9 and the gRNA needs 
to be validated in vivo. A mimivirus specific CRISPR-Cas9 would open the door to 
studies of not only mimivirus glycosyltransferases but any kind of gene or whole 
groups of genes giving valuable insights about the functionality of mimivirus proteins. 
MIMIVIRUS GLYCOSYLTRANSFERASES IN GLYCOENGINEERING 
It is accepted by now that glycan structures play crucial biological and physiological 
roles. Glycosylation became a major concern in biopharmaceutical manufacturing, 
production of therapeutically relevant proteins and antibodies, and other bioactive 
molecules (13, 32-34). Glycoengineering can enhance in vivo activity and alter 
pharmacokinetic properties of therapeutic proteins (35). The production of certain, 
defined glycans, however, is still challenging. Microorganisms can be used as platforms 
for production of large amounts of therapeutic proteins. Using microbes is cheaper, 
more rapid and stable in comparison to protein production in mammalian cell lines. The 
produced proteins often show host glycan patterns which may differ from the desirable 
glycan patterns making glycoengineering necessary. Microbes can be used as cell 
factories for the production of proteins and the glycan structures can afterwards be 
added in vitro (36). Mimivirus glycosyltransferases could be produced and purified in 
reasonable quantities in vitro. The analyzed glycosyltransferases did not have 
transmembrane domains and it is therefore likely that they do not need to be embedded 
in an organelle membrane like ER or Golgi for proper functioning. This makes them 
good candidates for use in in vitro glycosylation. Mimivirus glycosyltransferases would 
be especially useful for core O-glycosylation and elongation of both O- and N-glycans. 
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As the sequon in giant virus N-glycosylation differs drastically from eukaryotic and 
prokaryotic sequons, putative mimivirus core N-glycosylation enzymes might not be 
useful for core glycosylation of eukaryotic target proteins (37, 38). 
MIMIVIRUS GLYCOSYLATION IN IMMUNOGENICITY 
Giant viruses are found in both fresh water and marine environment, they were isolated 
from soil and permafrost (1, 6, 7, 39). In case of mimivirus humans might come in 
contact with the virus by ingesting infected water or by inhaling virus particles as 
aerosols. In both cases mimivirus is probably taken up by macrophages which can 
trigger presentation of mimivirus peptides to the immune system (40). Many mimivirus 
proteins have eukaryotic origin which enhances the chances of cross-reactivity with 
endogenous proteins upon activation of the immune system (41). There are various 
examples of molecular mimicry caused by pathogen infection of humans. 
Autoimmunity is a common feature of hepatitis B and C virus infection inducing the 
production of autoantibodies which cause a broad spectrum of autoimmune diseases 
like cryoglobulinaemia, autoimmune thyroiditis, rheumatoid arthritis, and more (42). 
Streptococcus infection is associated with rheumatic fever induced by molecular mimicry 
of streptococcal group A M proteins and myosin (43, 44). These cases of molecular 
mimicry are protein or peptide related. A prominent example of carbohydrate mimicry 
is seen in Campylobacter jejuni infection. Carbohydrate mimicry between human 
ganglioside GM1 and a lipo-oligosaccharide of C. jejuni  
induces Guillain-Barré syndrome in patients (45, 46). A study in our group showed that 
mimivirus infection induces rheumatoid arthritis in mice. Immunization of mice with 
mimivirus total protein extract leads to generation of auto-reactive anti-collagen 
antibodies accompanied by rheumatoid arthritis syndromes. Interestingly, human sera 
of arthritis patients react to mimivirus collagen in a significantly higher level than sera 
from a healthy control group indicating a production of auto-antibodies upon exposure 
General discussion 
123 
to mimivirus(47). Given the fact that some mimivirus glycosyltransferases have 
eukaryotic homologs and most glycan structures are found on the surface of mimivirus 
particles it is possible that other mimivirus surface glycans induce autoimmune 
reactions making it particularly interesting to study und understand the synthesis and 
structures of the glycan shell of mimivirus. 
Mimivirus is a peculiar organism with manifold special features never seen in a virus 
before. We were able to gather further evidence for an independent glycosylation 
machinery in mimivirus. Identifying the functionality of R707 depicts an exception to 
the common rule of the functionality of a glycosyltransferase. R707 is not only flexible 
towards the linkage formed, which is known for a few other glycosyltransferases, R707 
is also capable of forming both α and β linkages, a feature never described for 
glycosyltransferases before. This finding might help understanding the general 
mechanism of glycosidic bond formation and underlines the importance of basic 
research in curious organisms like giant viruses. 
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